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Abstract 
Modern spectroscopic techniques grant various methods for a protein structure 
determination among with a ligand interaction. This work aims at probing the structural 
insights of a protein-small molecule interaction with biocrystallography and optical 
spectroscopies. Two independent systems were investigated in frame of this thesis. The 
first one involves flavoenzyme interaction with a natural nucleotide as a cofactor required 
for its catalytic activity and work was purely based on macromolecular crystallography. 
The second concerns incorporation of a synthetic fluorescent ligand into a model protein 
as a solution for hydrophobicity of the probe. Due to the nature of the probe optical 
spectroscopies (such as absorption, fluorescence lifetime, circular dichroism) were 
effectively employed together with crystallographic methodology.  
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Chapter 1 - Preamble 
 I. Structural studies of biological macromolecules – biocrystallography 
Contemporary structural biology employs various powerful techniques to 
investigate the structure of macromolecules at different levels and resolutions; among 
them X-ray or neutron diffraction (XRD), Small Angle X-ray Scattering (SAXS), Nuclear 
Magnetic Resonance (NMR), and Cryo-Electron Microscopy (Cryo-EM). All of them plays 
at the edge of physics, biology, chemistry, and engineering. The field requires very often 
hybrid approach, thus combining two or more techniques. Biocrystallography is the 
experimental science aimed to the study of the 3D structure of biological macromolecules 
at atomic resolution. It is based on the analysis of a diffraction pattern of a crystal, targeted 
by a radiation beam, in general X-ray. Although the crystallization of biological 
macromolecules could be the bottleneck of the entire procedure, biocrystallography 
remains dominant and allows for an atomic resolution structure, eventually giving access 
to the function evaluation. 
Historically this field is not only knowledge-based but also technology and methodology 
driven. Regular advancements had been done in emerging aspects of biocrystallography, 
starting from protein expression and purification and ending up with diffraction data 
collection at synchrotron sources and model refinement. As Giegé et al. (2010) nicely 
phrased this evolution:  
"Over the years with the increasing number of solved crystal structures, 
biocrystallography reached the mature age and transformed into structural biology." 
Difficult to argue with such statement considering the number of cooperative networks 
doing extensive work in the structure determination by employing more and more 
advanced technologies. Many European institutes allow researchers to access almost any 
kind of instrumentation with a support of experienced scientists (i.e. EMBL, IBS, Instruct 
facilities). 
Figure 1 represents steps that are essential in 3D structure determination by the 
crystallographic approach. The very first step is the preparation of the target 
macromolecule sample, that is based on biological methodologies (cloning, expression, 
purification and purity assessment). The further three steps deal with rather 
2 
interdisciplinary approaches to get high-quality diffraction data from the protein crystal. 
The main condition to reach this aim is to grow highly ordered single crystals. Methods 
were developed to screen initial conditions and pick the right method for crystal growth. 
The complexity of the crystallization matrix makes it more a trial and error approach, but 
when the first crystals are obtained an optimization procedure can be applied by rationally 
varying few parameters with the aim of improving morphology and dimensions.  
Sometimes these two steps can require a long time. The determination of the final 3D 
structure consists of two stages: the phase determination which is not a trivial task in the 
case of biological macromolecules and the structure refinement. Many software are 
currently available for the diffraction data analysis, phase determination and structure 
refinement. Being constantly updated they keep the crystallographers with most recent 
advancements. 
A crystallographic project can be stuck at any of these stages forcing search for an 
alternative solutions and re-attempting the job all over again. As will be demonstrated in 
this work, it is the case where some problems are difficult to overcome but remains 
solvable to some extent. Methodology details will be provided further on in this work. 
  
Figure 1. The schematic protocol employed in a biocrystallographic project. 
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 II. Protein-ligand interactions 
Proteins play a vital role in living systems and are very complex molecules. 
Typically, the amino-acid sequence shapes the protein structure and function but very 
often to perform their work a protein needs a "little help" from different molecules. The 3D 
structure of such proteins usually shows a distinct binding site for these molecules. Any 
molecule bound to a protein and forming a complex with it is referred as a ligand (from 
Latin ligare meaning to bind). Ligands include substrates, inhibitors, activators and 
neurotransmitters and they can be peptides, proteins, DNA, small molecules, ions, and 
drugs. 
A well-known example would be hemoglobin, which is a protein responsible for the oxygen 
transport in vertebrates. This would not be possible without iron atoms. Each hemoglobin 
carries four distinct, non-covalently bonded heme groups – each one accommodating one 
iron atom. Once it binds to dissolved oxygen atoms, the protein can transport oxygen from 
lungs to tissues - graphical representation shown in Figure 2. 
 
Figure 2. Hemoglobin mode of action. Each hemoglobin contains four distinct iron-containing heme groups. 
Oxygen is loaded during respiration. Once the tissue is reached deoxygenation takes place, and 
metalloprotein can continue the cycle. Image taken from stepwards.com website (access on May 8th 2017). 
There are plenty of such examples, and each would have a unique mechanism. The order 
of interaction between the protein and a ligand lays within weak, non-covalent bonds such 
as salt bridges, hydrogen bonds, and Van der Waals forces. The binding site specificity is 
related to the nature of R-groups (amino acids side chains) mutual interaction, giving rise 
to a binding pocket within the protein structure. 
There are 20 common amino acids, very different in chemical character, thus being able 
to form different bonds. This is why those interactions are usually very specific.  
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There are many ways for amino-acids classification, and grouping them by their chemical 
character is the most convenient way to visualize types of a bond they can take part in. 
Hydrophobic interactions and Van der Waals forces stand for an important class in protein 
science, thus giving a significant role to non-polar residues, such as aliphatic (Gly, Ala, 
Val, Leu, Ile, and Pro) and aromatic (Phe, Tyr, Trp) ones. Non-polar groups contribute to 
change in entropy, since they are more stable when close to each other rather than 
exposed to water – this would be a basic description of hydrophobic interactions. Van der 
Waals forces are related to the charge of a molecule or more accurately - charge 
fluctuation. This behavior results in temporary charge attraction or repulsion of the 
neighboring electrons and atoms - eventually giving rise to the attractive forces.  
Charge-associated interactions would include acidic (Asp, Glu) and basic (Arg, Lys, His) 
residues (here charge-charge and ionic interactions). Ionic interactions tend to be stronger 
when considering amino acids containing alcohols (Ser, Thr, Tyr) or amides (Asn, Gln) 
because of the presence of either oxygen or nitrogen atom and their electron withdrawing 
properties. Their polarity makes them a good fit for hydrogen bonding, between N-H, O-H 
hydrogens, and a lone pair on oxygen and nitrogen at an adjacent residue.  
Another important class of bonds in proteins are those forming disulfide bridges between 
Cys residues. Those are formed either within a peptide or between separate polypeptides. 
They form a covalent bond, meaning they need a catalyst to be formed or broken apart. 
They are responsible for many catalytic properties of certain enzymes, and an example is 
also given in this work. 
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 III. Aim of the study 
This thesis is based on the structural characterization of the protein-small molecule 
interactions in two independent systems: 
1. Glutathione reductase (GR) from the photosynthetic algae Chlamydomonas   
reinhardtii, which binds a flavin adenine dinucleotide (FAD) in each chain. This 
subject will be referred as PROJECT1 in this thesis. 
2. Bovine serum albumin (BSA) as a putative system to solubilize and carry in water 
solutions boron-dipyrromethene (BODIPY), a novel fluorescent dye. This subject 
will be referred in this thesis as PROJECT2. 
 
PROJECT1: Glutathione reductase plays a significant role in the cell homeostasis by 
maintaining a reducing environment within a cell. In photosynthetic organisms it is present 
in several cell compartments, thus giving rise to different isoforms. Even though its 
function and mode of action are believed to be well conserved in nature, there is little 
known about this structure of plant origin. 
In Protein Data Bank (PDB) at the moment there are 36 structures of GR, but any of these 
from photosynthetic organisms.  
The target of this project is to determine the three-dimensional structure of two GR 
isoforms, namely glycolytic (GR1) and chloroplastic (GR2), characterize the interaction of 
the protein with FAD with a focus on Rossman fold holding the cofactor and to perform a 
comparative study with other GRs of different origin already characterized. 
This work is a collaborative project between plant physiology and biocrystallography group 
at the University of Bologna. The first one being responsible for biochemical 
characterization (including expression and purification) and latter for obtaining high-
resolution structure and probing interactions. Once purified to homogeneity, the protein is 
taken for crystallization trials. If positive results are obtained, crystallization conditions 
have to be optimized to get a representative, high-quality crystals. Those are then taken 
to macromolecular crystallography beamline at Synchrotron light source for the diffraction 
data collection.  
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PROJECT2: Fluorophores having excellent photophysical characteristics were always in 
demand in every area of natural and life sciences. First syntheses and characterization of 
boron-dipyrromethene fluorescent dyes were performed in 1968 but gained popularity 
quite recently. Their characteristics were real El Dorado in fluorescent tools as stated by 
Ziessel et al. (2007).  
Due attractive fit in cell imaging it became an interesting aspect to investigate BODIPY 
interaction with proteins. One of the drawbacks of these molecules is their very low 
solubility in water, and their use in complex with proteins could be a smart way to 
overcome this problem. 
Thus, the aim of this project is to develop a procedure for preparation of protein-BODIPY 
adduct and characterize it by a spectroscopic and crystallographic approach for probing 
protein-small molecule interactions. The choice of the protein was addressed toward 
proteins commercially available and well characterized as Bovine serum albumin (BSA).   
Emphasis is on spectroscopic characterization to investigate photophysical properties of 
the dye when incorporated in protein (optical spectroscopy approach) and structural 
insights to see the range of interactions and explore potential binding pocket 
(biocrystallographic approach). Applying hybrid methods gives a complete image of 
protein-small molecule behavior regarding photophysical and chemical stability, being a 
good starting point for further research in the area. 
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PROJECT1 
 
Chapter 2 - Introduction 
 2.1 Biological importance and catalytic mechanism of Glutathione Reductase 
Abundant in most organisms Glutathione Reductase (GR) or Glutathione Disulfide 
Reductase (GSR) is an enzyme that is conserved among all kingdoms, it has a well-
defined role in cells and for a number of organisms, its enzymatic activity mechanism is 
well understood. Its key role is to resist an oxidative stress when needed and to control 
reducing environment of the cell. Indeed, it catalyzes the reduction reaction of glutathione 
disulfide (GSSG) to glutathione (GSH). [1] 
Glutathione (γ-L-Glutamyl-L-cysteinyl-glycine) is a water soluble tripeptide. GSSG 
consists of two GSH molecules linked by the disulfide bridge, as shown in Figure 3A. 
Glutathione as a ubiquitous thiol-containing tripeptide participates in its reduced form 
(GSH) in several functions of vital importance to the cell. [2] 
GR is a homodimer employing flavin adenine dinucleotide (FAD) and nicotinamide 
adenine dinucleotide phosphate (NADPH) to efficiently convert one molar equivalent of 
GSSG into two equivalents of GSH. The schematic mechanism is based on proton 
donation/acceptance as in Figure 3B. The enzymatic mechanism of GR is of ping-pong 
type and is connected to the reductive and oxidative half reaction. This process is 
facilitated by a few conserved residues which are discussed in details in proceeding sub-
chapter. 
GR catalytic activity is NADPH-dependent process involving cysteine (Cys) residues. 
Disulfide reduction reaction of GSSG to GSH is initiated by FAD through the nucleophilic 
attack. The process is based on sulfur biochemistry, thus it requires an electron relay that 
would link reducing NADPH with thiol/disulfide and thiol containing adapter molecule to 
transfer an electron to different acceptors (here GSH). [3] 
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 2.2 Glutathione Reductase role in eukaryotes 
The structure and function of GR in pro- and eukaryotes is well known for years. 
GR in plant eukaryotes is found in chloroplasts, mitochondria, and cytosol. 
From functional aspect GR catalytic properties are essential for efficient removal of 
dangerous Reactive Oxygen Species (ROS) being, for instance, hydroxyl radicals (∙ OH), 
singlet oxygen (O2
1) and other electrophiles. In human cells it was reported that GR 
function is in fact much more than that, being responsible for metabolism and clearance 
of xenobiotics, regenerating antioxidants (such as vitamin C and E) to their active forms 
and acting as a cofactor in detoxifying enzymes. [1] 
GR was first purified from baker’s yeast in 1955 by E. Racker at Yale, who also described 
electron donor properties of NADPH in this enzyme. Ten years later his group also verified 
a presence FAD and thiol group leading to the first mechanism proposal. Since then many 
molecular insights of this enzyme had been unrevealed along with structure determination 
at 3 Å resolution by Schulze et al. (1978) and up to now it remains an extensively studied 
flavoprotein. [4] 
 
 2.3 Abiotic stress defense in plants 
ROS are generated in living organisms as byproducts of causal metabolic 
pathways. Abiotic and biotic stress is considered to be of critical importance in the 
maintenance of a cell cycle and homeostasis. Abiotic stress by simplest definition is a 
negative influence of non-living factors on the organism at specific conditions (here 
environment). This includes drought, flooding, radiation, temperature, nutrient access and 
wind. Each of these is unavoidable to some extent when we consider plants, and they 
speed up ROS formation in a cell. At low ROS levels, the cell performs its vital functions, 
such as cell growth, pathogenic defense and/or development. When this is not the case - 
thus ROS and oxidants are exceeding the levels of vital antioxidants - the resulting events 
may be severe for a cell, leading to protein, lipids, carbohydrates and/or nucleic acids 
damage. Not surprisingly this may cause cell malfunction and death.  
Plants have developed powerful metabolic pathway in preventing ROS-related reactions 
– ascorbate-glutathione (AsA-GSH) cycle. The process starts with hydrogen peroxide 
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being reduced to water, utilizing ascorbate peroxidase (APX) with an ascorbate as an 
electron donor. Oxidized ascorbate radical gets reduced by monodehydroascorbate 
(MDAR) reductase but since it is a radical the reduction has to be very efficient, otherwise, 
dehydroascorbate and ascorbate are formed. This is the point where GSH is crucial to 
effectively convert dehydroascorbate into ascorbate with help of dehydroascorbate 
reductase (DHAR). After reduction step, GSH is oxidized to GSSG. Furtherly GSH is 
recovered by glutathione reductase, requiring NADPH as an electron donor. 
The GSH/GSSG ratio has to be normally maintained in favor of GSH to effectively get 
through abiotic stress. 
Figure 3. Scheme of redox reaction upon GR catalytic activity. (A) Simplified representation of sulfur 
biochemistry in 2GSH/GSSG. Withdrawal of electrons from thiol groups leads to formation of sulfur bridge, 
thus oxidized form of glutathione. (B) Global representation of redox reactions with participation of FAD-
bound GR and accompanying oxidation of NADPH.   
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Flavoproteins plays a role of an electron relay, and reducing NADPH hence enters the 
cycle with the guidance of GR-FAD complex yielding 2 molecules of GSH. The scheme of 
this cycle is shown in Figure 3B. GSH furtherly serves as a reducing agent for disulfides 
and hydroperoxides or conjugates with 2-oxoaldehydes (2-OA) and electrophiles. 
Summing up, disulfide reducing properties of GR makes it of critical importance in removal 
and/or conversion of electrophilic substances and xenobiotics. This process also 
demonstrates the adaptability of glutathione-based catalysis as an explanation of various 
chemical challenges in our understanding of evolution. [1] 
 
 2.4 Glutathione reductase structure and enzymatic characteristics 
As shortly mentioned before GR crystal structure was determined in 1978 at 3 Å 
resolution by Schultz et al. and its characteristics was advancing through sequence 
assignment in 1981 (from crystallographic data at 2 Å by Thieme et al.), genetic screens 
and redox catalysis. Today GR is one of the best-understood enzymes. [5] 
GR is a flavoenzyme belonging to the family of pyridine-nucleotide-disulfide-
oxidoreductases. Despite the fact that it is found in certain isoforms in both pro- and 
eukaryotes it forms a stable homodimer with an approximate mass of ~110 kDa shown in 
Figure 4A. Each subunit contains two distinct Rossman folds accommodating FAD and 
NADPH. The flavin ring of a FAD molecule separates the binding sites for NADPH and 
their spatial orientation within an enzyme is presented in Figure 4B. In a case of GSSG, 
the binding takes place at the interface between GR monomers, implying that this enzyme 
is functional only in its homodimeric form. The cofactor binding domains are known from 
GR crystal structures of E. Coli, H. Sapiens, and S. Cerevisiae, where interface domain is 
known to be responsible for dimerization and comprises two regions involving residues 
located at C- and N-terminus of the protein. Significant sequence variation in GR 
structures occurs around position 75 (interface domain). In this region, E.Coli GR has an 
antiparallel intersubunit β-sheet from 71 to 80, H. Sapiens GR has an intersubunit disulfide 
bridge (C90–C90’), and  S. Cerevisiae GR sequence from 73 to 88 formed more tight 
extended intersubunit antiparallel α-helices. The most important feature of the crystallized 
GRs is that they all contain an intersubunit in the active site. This bridge is opened when 
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NADPH binds to the oxidized enzyme. In this form, GR is capable of attacking GSSG and 
a mixed disulfide is formed. 
It is commonly believed that GR structure by means of both substrate binding and the 
amino-acid sequence is well conserved in the course of evolution among all kingdoms. A 
small distinction is assumed for the subunit interface, yet as demonstrated in proceeding 
chapters plant GR enzyme differs quite significantly from human isoforms. Least 
conserved residues for a variety of organisms are Cys residues, playing usually regulatory 
role. [6]  
In the context of function, GR being an oxidoreductase has three substrates, namely 
NADPH, H+ and GSSG and two products (2 molecules of GSH). Schematically its role in 
metabolism was already presented in Figure 3B. A similar observation can be withdrawn 
when considering isoforms balance, which for instance in yeast was reported to be 
regulated by translation initiation efficiency. [7]  
GR high resolution structure has been reported for certain pro- and eukaryotic organisms 
varying from 1.55 Å up to 2.6 Å. It is essential to know sequence and structure similarities 
in order to confirm interactional features within an enzyme. Based on PBD search 8 
structures from different organisms were taken under consideration being namely: 
Yersinia pestis (gram-negative bacteria), Streptococcus mutans (gram-positive bacteria), 
Vibrio parahaemolyticus (gram-negative bacterium), Bartonella henselae 
(proteobacterium), Saccharomyces cerevisiae (yeast), Plasmodium falciparum 
(protozoan), Escherichia coli (gram-negative bacteria) and Homo sapiens. This simply 
means there is no single structure being reported for plants. 
 
 
 
Figure 4. GR homodimer with its binding sites from Escherichia coli. (A) Subunit 
representation of an enzyme and (B) FAD and NADPH spatial orientation within GR 
with surrounding residues. The catalytic activity is located at the interface between GRs 
monomers. Images generated with PDB viewer, PDB ID: 1GET 
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 2.4.1 Reductive half-reaction of Glutathione reductase 
Oxidized state GR (GRox) involves two cysteine (Cys47B and Cys42B for bacterial 
GR) residues forming disulfide bridge on the ‘back’ side of isoalloxazine ring of the FAD. 
The noteworthy disulfide bridge is in the proximity of histidine residue (His439A) which is 
hydrogen bonded to glutamic acid (Glu445A) – where both of these residues belong to 
the A subunit of GR homodimer. On the other side (facing NADPH) of flavin, there is also 
tyrosine residue which acts as a shield for FAD and stands for a gate-keeper at NADPH 
site. Once NADPH site is filled the tyrosine ring rotates away from flavin ring and locks 
the nicotinamide group of NADPH. Then hydride from NADPH reduces FAD to FADH- 
which furtherly transfer electron pair to the neighboring cysteine residue (Cys47B). This 
gives rise to stable charge transfer complex with a flavin ring. The other Cys residues are 
protonated by a histidine residue. [8][9] Up to this point, there is two-electron reduced 
enzyme (GRH2), NADP+ is then dissociated leaving space for another NADPH molecule. 
[10] Scheme of a simplified mechanism of this redox cycle is shown in Figure 5. 
 
 2.4.2 Oxidative half-reaction of Glutathione reductase 
Oxidative part of enzymatic catalysis of GR starts with GSSG binding to reduced 
enzyme GRH2 accompanied by tyrosine residue reorientation, so that its hydroxyl group 
is pointing at disulfide bridge of GSSG. It also stabilized by other conserved residues from 
both subunits of homodimer – four positively and two negatively charged residues 
compensating substrate charge. Then the substrate is attacked by interchange residue 
Cysint (Cys47B) which in consequence forms a mixed disulfide bond. The His (His439A) 
residue withdraw the proton from Cysint accelerating the nucleophilic attack overall. 
Protonated His will then give off its proton in favor of one thiolate group of GSSG that is 
being reduced. The reaction is supposed to take place in accompany of Tyr residue. 
[9][11] Once the GSH group detaches from the active site, the mixed disulfide bond is 
being attacked by sulfur atom of CysCTC (CTC - Charge Transfer Complex) oxidizing GR 
back again. Second GSH molecule gets a proton from same His residue closing the cycle. 
The rate of these reactions was reported to be not constant in time, since one of the 
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protonation steps serve as a rate limiting step in terms of kinetics. [11][12] Nonetheless 
His plays influential role in GR enzymatic catalysis.  
Current understanding of this process is rather well established, but still, there are many 
open questions about mechanistic details, including source and fate of protons, role of Tyr 
residue, which Cys residues are protonated by His and what is the order to this redox 
process, is it sequential or does it happen simultaneously? 
 
 2.5 Chlamydomonas reinhardtii as a model organism for GR studies 
C. reinhardtii is a single-cell, eukaryotic green alga being soil and freshwater 
abundant organism. Its cell wall is made of hydroxyproline-rich glycoproteins and has a 
large cup-shaped chloroplast with light-sensible eyespot. It is a very popular model 
organism in biology due to ease of culturing and simplicity of genetic manipulation. It also 
has notable cell cycle feature of growing photoautotrophically under light illumination and 
in the dark if organic carbon is supplied. Many questions in molecular biology were 
resolved with C. reinhardtii, demonstrating how do cells move, behave under light 
irradiation, recognize one another or react to changes in mineral nutrition. From the 
biotechnological view, it is a meaningful organism in biopharmaceuticals and biofuel 
production as well as a tool in hydrogen generation. [13] 
Figure 5. Schematic representation of oxidative and reductive half reaction of GR. Image taken from [1]. 
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There are many mutants of C. reinhardtii and they are extensively used for a study of 
various biological processes, like flagellar motility, photosynthesis or protein synthesis. 
These species are normally haploid so that the effects of mutations are seen immediately 
without further crosses. Those facts make this organism a very good fit for a comparative 
study of plant-based enzymes. 
In C. reinhardtii GR is present in all cellular compartments, such as chloroplasts, 
mitochondria, endoplasmic reticulum, vacuoles, and cytosol. Chloroplast and 
mitochondrial GR is encoded by gr2, while gr1 encodes a protein that is found in the 
cytosol and peroxisomes (Kataya and Reumann, 2010). In Chlamydomonas reinhardtii 
there are two genes encoding GR: the product of GSHR1 is cytosolic, and the product of 
GSHR2 is plastidial (Merchant et al., 2007). 
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Chapter 3 - Methods and experimental fine points 
This chapter deals with protein preparation, protocols and basic instrumental 
insights needed to determine the protein structure. Protein preparation, thus expression 
and purification were performed by the Plant Physiology group at Department of 
Pharmacy and Biotechnology (FaBit) of the University of Bologna. 
 
 3.1 Protein preparation and purification 
The pET3 plasmids containing the cDNAs encoding Chlamydomonas reinhardtii 
proteins glutathione reductase 1 (GR1) and glutathione reductase 2 (GR2) were kindly 
provided by Dr. Stephane D. Lemaire from the Institut de Biologie Physico-Chimique 
(IBPC) in Paris (France). 
Plasmids were introduced into BL21 E. Coli competent cells and positive clones from 
antibiotic selection were cultured in the LB (Luria-Bertani) medium. Culturing was done at 
37 °C, over 16-18h with continuous shaking. About 8 mL of culture was transferred into 
800 mL of fresh LB medium and again grown at 37 °C until an optical density of 0.4-0.5 
at 600 nm was reached. Protein expression was induced by 0.2 mM IPTG and left for 3 
hours for GR1 and for 16-18 hours for GR2 (at 30 °C). Then cells were harvested by 
centrifugation (8000 xg for 20 minutes), the pellet was washed with buffer and pelleted 
again before storage at -80 °C. Frozen pellet was re-suspended in binding buffer (20 mM 
Tris-HCl, 0.5 mM NaCl, 5 mM imidazole, pH 7.9) and taken for 3 cycles of French Press. 
Cell debris was removed by centrifugation and supernatant containing recombinant 
enzyme was recovered. Purification was done with Ni-NTA affinity column and after 
extensive washing with step-gradient concentration of imidazole (30 and 60 mM), the 
elution was performed in the presence of 250 mM imidazole. Eluted fractions were 
desalted using PD-10 columns (GE-Healthcare) equilibrated with Tris-HCl 30 mM, pH 7.9. 
Purified recombinant proteins were concentrated using Centricon filters and stored at -20 
°C. 
The electrophoretic analysis was done with SDS-PAGE with 12% acrylamide gels and 
stained with Coomassie Blue (40% ethanol, 12% acetic acid, 0.25% Coomassie Blue R-
250). Bleaching was done with destaining solution (40% ethanol, 10% acetic acid). 
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 3.2 Dynamic Light Scattering 
To check the oligomeric state of the protein, Dynamic Light Scattering (DLS) 
measurements were performed. DLS is a technique that measures the dimension of 
particles in solution, in a submicron range. The measurement is based on relating 
Brownian motion to the size of a particle. The larger the particle the slower the Brownian 
motion. For the DLS measurement, the temperature has to be accurately known since it 
requires viscosity information for data evaluation. The velocity of the Brownian motion is 
defined by the translational diffusion coefficient. For this reason, it is essential to keep the 
temperature stable throughout the experiment. 
The DLS spectrophotometer is constituted by a laser light source illuminating the sample 
contained in the cell, which causes the scattering of light recorded by the detector. It 
measures the time-dependent fluctuations in scattered light from a solution of molecules 
to determine the hydrodynamic radius (RH) from the Stokes-Einstein equation 
d(H) =
kT
3πηD
 
Where: 
d(H) – hydrodynamic diameter 
D – translational diffusion coefficient 
k – Boltzmann’s constant 
T – absolute temperature 
η – viscosity 
The diameter in DLS measurement is referred as how particle diffuse in a fluid thus it is 
named hydrodynamic diameter. This statement directly entails other parameters to be of 
high importance such as concentration and chemical character of a sample. The 
translational diffusion coefficient is dependent in fact on the size of the particle, ionic 
strength of the medium (affecting diffusion speed), surface structure (surface change can 
affect apparent size of the particle), and non-spherically shaped particles. 
DLS from a physical point of view is dominated by the scattering phenomenon. This can 
be split into two elementary types of scattering being namely Rayleigh and Mie scattering. 
The first one says that if the particles are small compared to the wavelength of the laser 
used (typically ~600nm), then the light scattered from the particle will be isotropic. The 
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Rayleigh theory tells us that intensity of light scattered is inversely proportional to the 
particle diameter to the power of six 
I ∝ d6 
and 
I ∝
1
λ4
 
In practice, this means that if there is a hypothetic particle 50 nm in size it will scatter 106 
as much light as a 5 nm particle. This implies a conclusion that light from large particles 
will suppress the light scattered from the small ones. Mie concept of scattering says that 
if the size of particles become similar to that of the wavelength of incoming light then a 
complex function of maxima and minima in respect to the angle is observed. 
The DLS measurement to be reliable needs to be correlated with either two independent 
signals or same signal in a time domain in search for similarity degree. If the intensity of 
a signal is compared with itself at a particular point in time and a time much later, then for 
a randomly fluctuating signal it is obvious that the intensities are not going to be related in 
any way. Knowledge of the initial signal intensity will not allow the signal intensity at time 
t = ∞ to be predicted. However, if the intensity of a signal at time = t is compared to the 
intensity a very small time later (t + δt), there will be a strong relationship or correlation 
between the intensities of two signals. The two signals are strongly or well correlated. If 
the particles are large the signal will be changing slowly and the correlation will persist for 
a long time. If the particles are small and moving rapidly then the correlation will reduce 
more quickly. [14] 
The DLS measurements were  done with a Zetasizer Nano ZS, Malvern, with a laser 
source He-Ne (633 nm, 5 mW) at a temperature of 25 °C, in a 100 μL cuvette with 30 mM 
Tris-HCl 30 mM (pH 7.9), and the concentration of analyzed samples was 1 mg/mL for 
each protein (CrGR1and CrGR2). The correlator compares the intensity of scattering in 
subsequent time intervals and sends the data to a software to be analyzed. The reported 
hydrodynamic radii (RH) for each protein sample have been averaged from the values 
obtained from five measurements each one composed of ten runs of 10 seconds. 
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 3.3 Crystallization 
In XRD experiment it is crucial to have high-quality crystals. To achieve that many 
strategies have been explored with varying outcomes. Normally the protein purity is 
essential along with its properties under physiological conditions (such as solubility and 
activity). These properties make often crystallization rather unpredictable, thus requiring 
trials, and optimizations if satisfactory conditions are found.  
Crystallization is a process purely dominated by the laws of the physical chemistry. In this 
context, there is no difference in crystallizing sodium chloride (NaCl) or macromolecular 
complex. The difference relies on a 
method of bringing the molecule of 
interest to the supersaturation level. 
While for low molecular weight 
compounds (either organic or inorganic) 
this is not considered a problem, for 
proteins the supersaturation level cannot 
be reached for example by simple solvent 
evaporation or extensive heating and 
dissolving. To crystallize means to 
gradually decrease the solubility of an 
analyte so that it will precipitate and eventually transition from liquid to solid phase would 
result in a crystalline material. Schematic phase diagram for protein is presented in Figure 
6. The undersaturated region stands for a region of the soluble protein. Then the solution 
overcome the solubility curve entering the metastable region and even though in the 
supersaturated conditions the nucleation cannot take place, but when the crystalline 
nucleus are formed they can grow crystals. The labile zone is a region when crystals can 
nucleate and growth takes place quicker and is less stable. The last step in crystallization 
apart from nucleation and crystal growth is termination step. It takes place when 
supersaturation is lost due to solid phase formation and solubility curve is reached. 
Crystallization of proteins is normally facilitated through addition of several compounds 
affecting the physicochemical character of the solution, like for instance protein 
concentration, precipitating agent nature and concentration, ionic strength, pH, 
Figure 6. Phase diagram for generic protein. 
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temperature and dielectric constant of the solvent. The precipitant promotes 
macromolecule aggregation, by reducing solvation shell of the protein since they will 
compete for water molecules. To reach this there are few groups of compounds utilized, 
such as salts, polymers, and organic solvents. For example, salts will increase the ionic 
strength due to dissociation and will stabilize protein through interaction with solvent-
accessible charged residues. Polymers increase molecular crowding. Polymer and protein 
will compete for water molecules brought by hydrogen bonds with hydroxyl moiety and 
eventually amplify protein-protein interaction. A similar mechanism is accepted for 
organics that withdraw the water molecules form solvation shell of the macromolecule. 
Next important compositional feature of crystallization solution is the buffer that 
determines pH. Its value affects the charge distribution on a protein surface (pKa and pI 
values). The pH range is also critical for protein stability. The crystallization solution 
composed of precipitant, buffer and salt/additive is commonly referred as a reservoir 
solution. Last crucial parameter in crystallization is the temperature since it directly affects 
the protein solubility and crystal growth rate. It is necessary to keep it constant to have 
controlled crystallization growth conditions. 
Up to now, there are certain methods for carrying out crystallization step and this includes 
vapor diffusion, micro batch, dialysis and free-interface diffusion. 
Vapor diffusion is found to be very effective method for 
macromolecule crystallization and rely on a 
straightforward principle. The protein sample and 
respective reservoir solution chosen for crystallization 
are placed on a siliconized coverslip (in a small 
volume) and left for vapor equilibration with ‘mother 
solution’ being reagent mixture in sizeable volume 
(with respect to the drop). The scheme of such setup 
is presented in Figure 7 for the case of a hanging drop. 
The equilibration is finalized when the concentration of the reagent in the drop is equal to 
the one in the reservoir (here water leaving the drop). As the concentration of protein 
gradually increases it eventually reach supersaturation domain and starts to either 
Figure 7. Scheme of a hanging drop 
vapor diffusion method. 
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crystallize or precipitate – salting out. This strategy is cost effective, allows for many 
experiments at once and gives easy access to the crystals. [15]  
Batch crystallization is based on mixing the protein sample with reservoir solution in a 
small amount to form a micro-drop that is then covered with an oil to avoid or limit 
evaporation. The oil diffusive properties are varying, for example covering micro-drop with 
paraffin oil reduce the diffusion completely while AI’s oil (1:1 mixture of silicon and paraffin 
oil) will permit some extent of diffusion, hence bringing protein to the supersaturated state.  
In dialysis crystallization method, the protein solution is equilibrated against a large 
volume of reservoir solution through a membrane. The gradual increase of precipitant 
concentration will eventually lead to nucleation zone and crystal growth of the protein. 
Last, most effective (probably) and not accessible method is a crystal growth in 
microgravity conditions. The advantage of this approach is the reduction of a convective 
motions and sedimentation, meaning the crystal growth is more uniform, fewer 
contaminants present within the crystal and most importantly the quality of the crystals 
was reported to be of outstanding quality. Many successful and interesting examples of 
this method are listed in [16].  
Crystallization experiments were manually performed by the hanging drop vapor diffusion 
method, using a 24-well Linbro plate from Molecular Dimension. For the trial crystallization 
Structure Screen 1 cacodylate free from Molecular Dimensions had been used (MD1-01-
CF). It contains 50 screening solutions and most of them were tested. The reservoir 
solution compositions of MD1-01-CF is presented in Table 1 and extensive kits can be 
found in an additional information 1. For optimization, two extra kits were applied: JCSG-
plus (MD1-37) from Molecular Dimensions and Crystal Screen 2 from Hampton Research 
by picking a tailored composition. Some optimizations required manual preparation and 
are indicated as ‘manual’ in this work. 
The protein solution was maintained at a concentration of 10 mg/mL for all crystallization 
trials and was suspended in buffer and 2% EDTA solution. 2 μL of protein was placed on 
a siliconized coverslip and mixed with another 2 μL of mother solution from the reservoir 
(700 μL). Each well was vaseline-sealed and left in an  incubator at 20 ± 1 °C. Control 
check was done every week under an optical microscope (Leitz Wetzlab SM-LUX) 
equipped with a digital camera Motic 5.0 MP. Figure 8A presents prepared plates for GR1 
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and 8B for GR2 for crystal screen and Figure 8C presents optimized conditions for GR1. 
A number of crystallization trials differ for GR1 and GR2 due to different volumes available 
at given time. 
Table 1. Structure Screen 1 cacodylate free - tube composition used for crystallization trials. 
Tube# Salt Buffer pH Precipitant 
1 0.02 M calcium chloride 0.1 M sodium acetate 4.6 30% v/v MPD 
2 0.2 M ammonium acetate 0.1 M sodium acetate 4.6 30% w/v PEG 4K 
3 0.2 M ammonium sulfate 0.1 M sodium acetate 4.6 25% w/v PEG 4K 
4 None 0.1 M sodium acetate 4.6 2.0 M sodium formate 
5 None 0.1 M sodium acetate 4.6 2.0 M ammonium sulfate 
6 None 0.1 M sodium acetate 4.6 8% w/v PEG 4K 
7 0.2 M ammonium acetate 0.1 M tri-sodium citrate 5.6 30% w/v PEG 4K 
8 0.2 M ammonium acetate 0.1 M tri-sodium citrate 5.6 30% v/v MPD 
9 None 0.1 M tri-sodium citrate 5.6 20% v/v 2-propanol, 20% w/v PEG 
4K 
10 None 0.1 M tri-sodium citrate 5.6 1.0 M ammonium dihydrogen 
phosphate 
11 0.2 M calcium chloride 0.1 M sodium acetate 4.6 20% v/v 2-propanol 
12 None 0.1 M MES 6.5 1.4 M sodium acetate 
13 0.2 M tri-sodium citrate 0.1 M MES 6.5 30% v/v 2-propanol 
14 0.2 M ammonium sulfate 0.1 M MES 6.5 30% w/v PEG 8K 
15 0.2 M magnesium acetate 0.1 M MES 6.5 20% w/v PEG 8K 
16 0.2 M magnesium acetate 0.1 M MES 6.5 30% v/v MPD 
17 None 0.1 M imidazole 6.5 1.0 M sodium acetate 
18 0.2 M sodium acetate 0.1 M MES 6.5 30% w/v PEG 8K 
19 0.2 M zinc acetate 0.1 M MES 6.5 18% w/v PEG 8K 
20 0.2 M calcium acetate 0.1 M MES 6.5 18% w/v PEG 8K 
21 0.2 M tri-sodium citrate 0.1 M HEPES 7.5 30% v/v MPD 
22 0.2 M magnesium chloride 0.1 M HEPES 7.5 30% v/v 2-propanol 
23 0.2 M calcium chloride 0.1 M HEPES 7.5 28% w/v PEG 400 
24 0.2 M magnesium chloride 0.1 M HEPES 7.5 30% w/v PEG 400 
25 0.2 M tri-sodium citrate 0.1 M HEPES 7.5 20% v/v 2-propanol 
26 None 0.1 M HEPES 7.5 0.8 M K/Na tartrate 
27 None 0.1 M HEPES 7.5 1.5 M lithium sulfate 
28 None 0.1 M HEPES 7.5 0.8 M sodium dihydrogen 
phosphate, 0.8 M K dihydrogen 
phosphate 
29 None 0.1 M HEPES 7.5 1.4 M tri-sodium citrate 
30 None 0.1 M HEPES 7.5 2% v/v PEG 400, 2.0 M 
ammonium sulfate 
31 None 0.1 M HEPES 7.5 10% v/v 2-propanol, 20% w/v PEG 
4K 
32 None 0.1 M Tris 8.5 2.0 M ammonium sulfate 
33 0.2 M magnesium chloride 0.1 M Tris 8.5 30% w/v PEG 4K 
34 0.2 M tri-sodium citrate 0.1 M Tris 8.5 30% w/v PEG 400 
35 0.2 M lithium sulfate 0.1 M Tris 8.5 30% w/v PEG 4K 
36 0.2 M ammonium acetate 0.1 M Tris 8.5 30% v/v 2-propanol 
37 0.2 M sodium acetate 0.1 M Tris 8.5 30% w/v PEG 4K 
38 None 0.1 M Tris 8.5 8% w/v PEG 8K 
39 None 0.1 M Tris 8.5 2.0 M ammonium dihydrogen 
phosphate 
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40 None None - 0.4 M K/Na tartrate 
41 None None - 0.4 M ammonium dihydrogen 
phosphate 
42 0.2 M ammonium sulfate None - 30% w/v PEG 8K 
43 0.2 M ammonium sulfate None - 30% w/v PEG 4K 
44 None None - 2.0 M ammonium sulfate 
45 None None - 4.0 M sodium formate 
46 0.05 M potassium 
dihydrogen phosphate 
None - 20% w/v PEG 8K 
47 None None - 30% w/v PEG 1.5K 
48 None None - 0.2 M magnesium formate 
49 0.2 M lithium sulfate None - 2% w/v PEG 8K 
50 0.2 M lithium sulfate None - 15% w/v PEG 8K 
 
 
 
 
Figure 8. Scheme of well numbering with a color indication respective to the crystallization kit used for GR1 
and GR2 crystallization trials and optimizations.  
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 3.4 Principles of Single Crystal X-ray Diffraction 
 3.4.1 X-ray Diffraction 
Single crystal X-ray diffraction is an analytical technique used for determining the 
atomic and molecular structure of a crystal. Crystalline material causes diffraction of an 
X-ray beam directed onto it. Once the crystal is grown it is mounted on a goniometer in 
order to place it in certain positions with respect to the incident beam (exemplary image 
provided in discussion chapter). Gradual rotation of a crystal gives a set of specific 
diffraction patterns. When focused, monochromatic and, coherent X-ray beam hits the 
crystal it will scatter light in many directions, appearing on a detector as regularly spaced 
spots – called reflections. Each of those is located at a specific position from the origin 
and has some intensity. Spots are named reflections because each of them corresponds 
to an X-ray beam reflected from an individual and evenly spaced planes within a crystal. 
Since the image is two-dimensional, and the ultimate aim is to get three-dimensional 
electron density map of the molecule determining the scattering,  those images are taken 
at many different crystal orientations. 
The X-ray diffraction is 
described by the Bragg’s 
law of diffraction 
(graphical representation 
in Figure 9). In Bragg’s 
model, each reflection 
has a set of evenly 
spaced planes in the 
crystal, passing through 
the centers of the atoms 
of the crystal lattice. These planes are classified with Miller indices (h,k,l) (or formally 
reciprocal lattice vector components) and spacing between the planes d. Bragg proposed 
that X-rays are scattered ‘mirror-like’ from the planes. As a consequence of this 
assumption, the beam scattered from adjacent planes will interfere constructively when 
the angle θ (between the plane and the beam) will result in path-length difference equal 
to integer multiple n of the beam wavelength. 
Figure 9. Graphical representation of the Bragg diffraction from a crystal 
with evenly spaced planes. 
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2d sin θ = nλ 
In more practical terms, reflection is indexed when Miller indices are established from 
known wavelength and scattering angle 2θ. This operation gives unit-cell dimensions, 
angles, and the space group. To obtain all the data required for structure determination 
that information has to be complemented by Fourier transform calculations that take into 
account relative intensities of the reflections. [17][18][19] 
A Fourier transform is a mathematical method for decomposing a signal into the 
frequencies that make it up. In spectroscopic analysis (or any other practical applications) 
this operation can be reversed to Fourier synthesis of a frequency domain representation 
that combines the contributions of all the different frequencies to recover the original 
function of time. This combined with chemical knowledge of a protein is essential in 
processing the electron density map to get valuable insights into a structure.  
From more theoretical approach the electron density f(r) throughout the crystal is 
assessed, where r corresponds to a three-dimensional position vector within the crystal. 
To reach this there is a need to collect all the data about its Fourier transform F(q), and 
then invert it mathematically (Fourier synthesis) in order to access the density defined in 
a real space. This is done with the formula 
f(r) =
1
(2π)3
∫ F(q)eiq∙rdq 
where the integral is calculated over all values of q. The vector q in a real space represents 
a point in reciprocal space, meaning it corresponds to a specific oscillation in electron 
density as one move in the direction in which q is pointing. The length of q resembles 2𝜋 
divided by the oscillation wavelength. Then the Fourier transform will be expressed as 
F(q) = ∫ f(r) e−iq∙rdr 
And here the integral is taken over all possible values of the position vector r in the crystal. 
The Fourier transform result is normally a complex number, that has a magnitude |F(q)| 
and phase φ(q) with the relation 
F(q) = |F(q)|eiφ(q) 
 
X-ray diffraction experiment gives the intensities of the reflections, thus magnitudes |F(q)| 
but does not provide any information about the phases φ(q). There are certain methods 
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to overcome this problem and its choice depends on the information available. Molecular 
Replacement (MR) is one way to go and is used only when a similar structure (threshold 
of ~30% for protein identity) is known. The model helps in regulating and determining 
molecule position and orientation. Here, the protein taken into consideration has similar 
structures characterized and uploaded on PDB, hence molecular replacement was found 
to be a good solution for the phase problem and allowed for electron density map 
generation. Other methods for solving the phase problem include: 
• Multiple Isomorphous Replacement (MIR) – where new diffracting centers are 
introduced to the lattice by soaking the crystal in a solution containing heavy atoms 
(and since they are electron-rich the contribution to the diffraction diagram will be 
pronounced). 
• Single or Multi-wavelength Anomalous Diffraction (SAD or MAD) – these two 
methods are based on an anomalous scattering of the inner electrons of heavy 
atoms. Here heavy atoms are considered those that can be naturally present in the 
protein as a cofactor or an amino acid (such Fe atoms or selenomethionine) and 
will absorb X-rays at a particular wavelength (absorption edge) and emit them with 
some delay. This delay causes phase shift that helps to localize them within the 
structure. 
 
 3.4.2 Synchrotron radiation source 
X-ray is a type of an electromagnetic radiation, generated in parcels of energy 
called photons. Its range of wavelength is between 0.01 and 10 nm. They are divided into 
two different-in-energy waves, first one called soft x-ray, and higher in wavelength called 
hard x-ray.  The energy range of x-rays lays in a range from 100 eV up to 100 keV. From 
a physical point of view, there are two atomic processes that are responsible for x-rays 
generation. The first one called white radiation (or Bremsstrahlung radiation), and the 
second one being K-shell emission. Both of those are related to heavy atoms elements 
and choice of an element depends on energy/application required. Due to their 
penetrating nature, they found to be an excellent tool for probing morphology of matter. 
[20] In scientific research, synchrotron radiation is preferred for an analysis due to its 
excellent properties.  
26 
Synchrotron radiation is a special type of light 
generation source in wide wavelength range 
and is considered as one of the most powerful 
radiation sources due to its collimation and 
linear polarization. [21] By definition 
synchrotron is a particle accelerator in which 
leading magnetic field is time-dependent, and 
as the name suggest particle beam is 
traveling in a synchronized path. If particles 
enriched with high energy are in rapid motion 
and travel in a curved path (induced by the 
magnetic field) the synchrotron radiation is generated (as an energy loss in a form of a 
photon). The scheme of a synchrotron light source is presented in Figure 10. The radiated 
power is given by the relativistic Larmor formula while the force on the emitting electron is 
given by the Abraham–Lorentz–Dirac force. The radiation pattern can be distorted from 
isotropic dipole pattern into an extremely forward-pointing cone of radiation. Synchrotron 
radiation is the brightest artificial source of X-rays. The planar acceleration geometry 
appears to make the radiation linearly polarized when observed in the orbital plane, and 
circularly polarized when observed at a small angle to that plane. 
The magnetic field in the synchrotron is varying in time in order to accelerate particles if 
almost relativistic speed is reached then the frequency of the electromagnetic field is 
adjusted to follow their abnormal circulation time.  The objective is to adapt parameters in 
such a way that as particles gain energy, all of them reach the same (thus constant) 
circulation path. The advantage of such design is vacuum chamber in shape of a thin torus 
(or ring). The profile of the ring makes more efficient use of a magnetic field. The toroid 
shape of large scale synchrotrons was found to follow strong focusing principle. [22] 
 
 
 
Figure 10. Synchrotron facility scheme. 
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The principal structures found at 
synchrotron are common for 
every facility of this kind (any 
details given here are associated 
to ESRF – European 
Synchrotron Radiation Facility in 
Grenoble). First, the storage 
ring, is an element giving 
characteristic shape to the 
facility. It is almost 900 m long 
tube, where electrons are kept at 
relativistic speeds and 
consequently have to be kept at 
low pressures (~10-9 mbar). As 
they travel in the ring they pass 
through different types of 
magnets (described below) to 
ultimately generate x-rays. 
Booster synchrotron is an 
element responsible for 
accelerating electrons before 
being injected to the storage ring. 
Having around 300 meters pre-
accelerator must give an energy 
of 6 billion electron volts (6 GeV) 
to the particles. It is in use only a 
few times a day for few minutes 
when storage ring needs to be 
re-filled. It can inject parcels of 6 
GeV electrons every 50 ms. Figure 11. Scheme of the main elements of the storage ring. 
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Linac is an abbreviation for the linear accelerator, and its role to generate electrons for 
the storage ring in a similar manner to classical cathode ray tubes. Here the electrons 
reach up to 200 million eV before entering booster synchrotron.  
X-ray beams emitted from electrons under magnetic field are directed into beamlines. 
Beamlines are located in tangent lines to the storage ring. Every beamline is designed for 
different experiments, thus having different characteristics for shaping the beam and 
adjusting the wavelength to the proper instrument for analysis. 
We can section the storage ring into function-specific devices. Major components of a 
synchrotron storage ring are: 
• Radiofrequency cavities – type of resonator consisting of a closed metal structure 
that restricts electromagnetic field in the microwave region of the spectrum. In 
synchrotron used for direct acceleration. 
• Dipole magnets (bending magnets) – electromagnet used for the creation of 
homogeneous magnetic field over some distance. Particles entering dipole magnet 
will travel in a circular or helical trajectory. In synchrotrons used for deflection of 
particles. 
• Quadrupole magnet (Q-magnet) – as the name suggest it is a group of four 
magnets fixed in a plane which caused multipole expansion of the field. The 
advantage of this magnet type is a creation of magnetic field that magnitude grows 
very rapidly with the radial distance. In synchrotron used for beam focusing. 
• Sextupole magnet – the principle is the same as in Q-magnet, but having 6 
magnets oriented with alternating north/south pole around an axis. 
• Wigglers are a series of magnets designed to periodically and laterally deflect 
('wiggle') a beam of charged particles (invariably electrons or positrons) inside a 
storage ring of a synchrotron. These deflections create a change in acceleration 
which in turn produces emission of broad synchrotron radiation tangent to the 
curve, much like that of a bending magnet, but the intensity is higher due to the 
contribution of many magnetic dipoles in the wiggler. 
• Undulators consist of a periodic structure of dipole magnets. The static magnetic 
field is alternating along the length of the undulator with a wavelength λ_u. 
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Electrons traversing the periodic magnet structure are forced to undergo 
oscillations and thus to radiate energy.  
The highest, reachable energy is relative to the maximum strength of the magnetic field 
and minimum radius of the particle path. To increase this energy limit superconducting 
magnets have been introduced (since they are not limited by so-called magnetic 
saturation). The cross-section of a storage ring components and the general working 
principle is shown in Figure 11. [23] 
 
 3.4.3 Data collection 
XRD experiments for both PROJECT1 and PROJECT2 were performed at ESRF 
in Grenoble (France) on ID23.1 beamline. This beamline is dedicated for macromolecular 
crystallography and split into 2 independent workstations. First one (ID23.1) designed for 
MAD (Multi-wavelength Anomalous Dispersion) measurements in the energy range from 
5 up to 20 keV and second (ID23.2) with fixed energy (14.2 keV) and a focused microbeam 
(8x6 micron).  
The characteristics of 
ID23.1 is the high 
demagnification ratio 
(1:4.5) that allows finely 
focused beam at a crystal 
position. This is 
advantageous in terms of 
protein samples that often 
give small crystals and 
even 20 µm crystals can 
be analyzed. The beam profile has Gaussian shape with FWHM (full width at half 
maximum) of dimensions 30 µm vertically and 40 µm horizontally with the continuous 
intensity monitoring system. 
The beamline is highly automated granting quick and reliable measurements while 
keeping it user-friendly. There is sample preparation room (if needed) equipped with 
optical microscopes. The user benefits from state-of-the-art diffractometers and sample 
Figure 12. ID23.1 beamline design for Macromolecular crystallography 
(MX). 
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changer. Remote semi-automatic sample alignment is possible from the control cabins, 
with experimental parameters calculated automatically based on pre-set user 
requirements. ID23-1 is equipped with a PILATUS 6M-F which has an active area of 2463 
x 2527 pixels and can collect 25 images per second with a readout time of 3 ms. The 
scheme of the beamline endstation is shown in Figure 12. [23] Diffraction images were 
recorded at 100 K, with a wavelength of 0.976 Å, an oscillation angle of 0.1°, a sample-
to-detector distance of 340.50 mm. A number of 3600 images, corresponding to all sphere, 
were recorded. 
 
 3.4.4 Data analysis and refinement 
The data collected at ESRF were saved for further processing with CCP4 software. 
[24] Firstly set of a diffraction data were chosen according to the best statistics and 
estimates. These include overall and outer shell parameters, such as resolution, I/σ, and 
multiplicity. Then mtz, pdb and fasta sequence files were collected for CCP4 software 
processing and model building. For phasing and molecular replacement the structure of 
40% identity was taken (PDB ID: 1DNA) according to the sequence alignment with Clustal 
Omega. After model building, amino-acid residues were manually substituted and fit into 
electron density map with Coot software [25]. 
The data at a resolution of 1.713 Å for GR1 were processed using XDS [26], scaled with 
SCALA [27] and TRUNCATE [28]. The correct space group was determined with 
POINTLESS [29] and confirmed in the structure solution stage. The data collection 
statistics are reported in the discussion section. 
The GR1 structure was solved by molecular replacement using the program MOLREP 
from CCP4 package. The coordinates of GR from Saccharomyces cerevisiae (PDB code 
2HQM) [30], deprived of chain B, FAD and water molecules, were used as search probe. 
The residual electron density map clearly showed the position of FAD, which was added 
to the model. Water molecules were automatically added and, after a visual inspection, 
they were conserved in the model only if contoured at 1.0 σ on the (2Fo – Fc) map and if 
they fell into an appropriate hydrogen bonding environment. All stages of the refinement 
were performed with REFMAC 5.5.0109 [31], alternate conformations, side chains 
positions if visible, were inserted/modified. The manual rebuilding was performed with 
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Coot. [32] There is also possibility to align subunits (or a whole enzyme) with use of 
LSQKAB software within CCP4 software package in order to visualize overlapping of the 
secondary structure elements of two different chains (for instance, GRs from two different 
organisms). 
The crystallographer deposits a model of the asymmetric unit of the crystal in the PDB, 
along with the experimental diffraction data (amplitudes and widths of the X-ray reflection 
spots, or structure factors) from which the electron density map can be reconstructed. 
Examining the relation between the published model and the electron density map 
provides clear insight into the uncertainties in the model than does merely examining the 
model itself. In addition to examining the entire map (2F0-Fc) it is revealing to examine the 
difference map (F0-Fc), which shows where the model fails to account for the map. 
Refinement is a continuous process of adjustment of the model to maximize the 
agreement of the structure factors of the model with the structure factors experimentally 
observed. For GR structure twelve cycles of refinement were performed with Refmac and 
with gradually decreasing R value. This agreement is mathematically expressed as  
R =
∑ ||Fhkl
oss| − |Fhkl
calc||hkl
∑ |Fhkl
oss|hkl
×100 
 
And generally its value lays in the range between 0.15 – 0.25 for well resolved structures 
(here 0.24). 
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Chapter 4 - Results and discussion 
Although a number of GR structures are found in PDB there is little known about 
plant origin isoforms. Sequence alignment shown low identity with bacterial, human and 
yeast isoforms, nevertheless certain structural features, like catalytic cysteines 
conservation. Yet it is important to investigate elementary processes like cell homeostasis 
in all kingdoms and plant one seems to be suffering from the little attention paid to 
structure-function relationships. Exposure to a drastically different environment and 
contrasting cell cycle makes plant proteins interesting objects for structural studies in 
terms of evolutionary biology.  
 
 4.1 Protein sample quality 
Biocrystallography requires high-quality material for repetitive crystallization 
experiments. Purification is crucial in this case since it will directly affect the rate, quality 
and likely morphology of the protein crystals. Glutathione reductase 1 and glutathione 
reductase 2 (GR1 and GR2) were expressed in E. Coli and purified to homogeneity by 
Ni2+ affinity chromatography. The yield of GR1 and GR2 products was 15 and 10 mg/L 
respectively. The GR1 sequence has 501 amino acid residues (Mw=53,128 Da) and GR2 
has 488 residues (Mw=52,124 Da), including the histidine tag required for purification (His-
tag peptide: MHHHHHHTM). The sequence of GR1 isoform is found in Uniprot database 
under the code of A8HXA6. The identity between GR1 and GR2 is little over 50% and 
pairwise alignment is presented below. 
GR1_cytoplasmic        -------MAEEYDLVTLGAGSGGVRASRFAATLYGAKVACVELPFGFVSSETVGGAGGTC 
GR2_chloroplastic      MASASAGEQFDFDLFTIGAGSGGVRGSRFAS-SYGAKVAVCELPFDYISSDTKGGVGGTC 
                                 ::**.*:********.****:  ******  ****.::**:* **.**** 
 
GR1_cytoplasmic        VIRGCVPKKLLVYGAAYAEEFADARGFGWALPAAGAGAEGGPAHDWASLMKLKEKEITRL 
GR2_chloroplastic      VLRGCVPKKLMVYASEYAEEFKASQGFGWTLPP------GAATHSWTAFIEAKRKELQRL 
                       *:********:**.: *****  ::****:**       *. :*.*::::: *.**: ** 
 
 
GR1_cytoplasmic        NSTYGNILKNANVALIEGRGALKDAHTVEVTAADGSVRLLKAKHVLIATGGVATAIPMEG 
GR2_chloroplastic      NGAYKNTLKNAKVELVEGRGRVVDAHTVEVDGK-----RYRAKNILIAVGGKPHKLDIPG 
                       *.:* * ****:* *:**** : ******* .        :**::***.**    : : * 
 
GR1_cytoplasmic        AEHAIMSDDALALQSLPPGPIVVLGAGYIATEFAGIFRGTHAAQYAVHLMFRGDKVLRGF 
GR2_chloroplastic      AELCITSDEALELPACP-QKVAVLGGGYIAVEFAGIFSRFGA---EVHTVYRQPLPLRGF 
                       ** .* **:** * : *   :.***.****.******    *    ** ::*    **** 
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GR1_cytoplasmic        DEECRDQVQDNLTRRGIHLHPGCKPTKLEKHGEGDLTLHYTDGTGAAQSL-KCGLVMMAT 
GR2_chloroplastic      DEEVRKFAAEQYAAAGLHLHAGCNPVSVSKQPNGKLSLVVKGPDGATSTLTDLDQVMMAT 
                       *** *. . :: :  *:*** **:*..:.*: :*.*:*  ..  **:.:* . . ***** 
 
GR1_cytoplasmic        RRKPRVDGIGLEAVGVALDGQGAIKVDEFSRTNVPDVWAIGDVTNRINLTPVALMEGMAF 
GR2_chloroplastic      GRVPKTSGLGLEEAGVKMGSKGQVLVDEYCRTNVPSIWAVGDVIDRIQLTPVALMEGMAV 
                        * *:..*:*** .** :..:* : ***:.*****.:**:*** :**:***********. 
 
GR1_cytoplasmic        AKSCFGGELTKPDYRNVASAVFCQPPLATVGYTEEQAVKEFAGNIDVYVSRFRPMKYTIS 
GR2_chloroplastic      AKSVAHNTPTVPDYFAVPSAVFSNPEIATVGYSEEQAAEKY-GDVDIYTTSFKPMRNTIS 
                       ***   .  * ***  * ****.:* :*****:****.::: *::*:*.: *:**: *** 
 
GR1_cytoplasmic        GREEKTLMKLIVHAESDVVLGCHMVGPDAPEIMQGLAVALKCGATKAQFDSTVGIHPTAA 
GR2_chloroplastic      GSPIRTFMKIVVDAASQKVVGMHMVGAEAAEIMQGFAVAVKVGATKQQLDSVVGIHPSAA 
                       *   :*:**::*.* *: *:* **** :* *****:***:* **** *:**.*****:** 
 
GR1_cytoplasmic        EEFVTMRSRSRRVPATGTSKL 
GR2_chloroplastic      EEFVTMRTVSRQVRKPA---- 
                       *******: **:*   .     
Sequence alignment between two GR isoforms from Chlamydomonas reinhardtii. The 
identical residues are marked with “*”, while similar amino acids are marked with “:”. The 
alignment performed with Clustal Omega online tool available on EMBL-EBI website. 
 
The molecular weight of a single protein chain was assessed by SDS-PAGE exhibiting 
bands around 50 kDa. The same electrophoretic profile was recognized for oxidized forms 
of GRs indicating a lack of intermolecular disulfide bridge(s) – indicated respectively by “-
“ for reducing and “+” for oxidized condition (Figure 13A).  
The quaternary structure of the proteins was estimated with Dynamic Light Scattering 
(DLS) experiment. This non-destructive technique gives immediate access to size 
distribution evaluation of small particles (not bigger than 1 µm) in solution as described in 
Methods and experimental fine points section. Since it is known that the biological 
assembly of GRs is a homodimer the expected molecular weight calculated from the 
hydration radius (Rh) would be the double of a single protein chain, thus around 100 kDa. 
The mean Rh based on the values from 5 independent measurements, resulted in a good 
accordance with the molecular weight of the dimer. Indeed, the Rh of GR1 was 5.17 ± 0.19 
nm, corresponding to an apparent molecular weight of 122 ± 2 kDa, and the Rh value 
determined for GR2 was 4.94 ± 0.22 nm, a value corresponding to an apparent molecular 
mass of 112 ± 3 kDa. Exemplary plot of size distribution by volume is shown in Figure 
13B. 
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4.2 Sequence analysis 
Protein required for a single and manual crystallization trial is about 1 to 5 µL, but 
when considering the range of possible conditions to grow an appropriate crystal, a 
number of trials have to be set up and thus larger volume is required. To limit this to some 
extent it is convenient to make an educated guess based on existing crystal structures 
and analyzing the protocols for crystallization. Indeed for GR, there are many crystal 
structures available on PDB from various organisms. The possible conditions were 
collected and identity evaluated. On the next page is shown sequence alignment for eight 
existing GR structures from human, few bacteria, yeast, protista with plant GR1. 
Transferases and glutathione amide reductases have not be considered in this 
comparative analysis. 
Multiple sequence alignment of GRs from different organisms was done with Clustal 
Omega from EBI online tools. The first code is an abbreviation of the organism name. 
Figure 13. (A) SDS-PAGE of GR1 and GR2.”+” indicates oxidized form, “-“ indicates 
reduced enzyme. (B) DLS analysis GR1 and GR2 reported as size distribution by 
volume in function of hydrodynamic diameter. 
A 
B 
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Chlamydomonas reinhardtii - ChRein,  Homo sapiens - HSapi, Plasmodium falciparum - 
PFalc, Saccharomyces cerevisiae - SCerv, Streptococcus mutans - SMuta, Escherichia 
coli - EColi, Yersinia pestis - YPest,  Bartonella henselae - BHens, Rhizobium meliloti - 
RMeli, Arabidopsis thaliana - AThal. In yellow catalytic residues are highlighted, hence 
cysteines, tyrosines, and histidines (while histidines are belonging the second subunit of 
an enzyme). Green markings indicate conservative mutations. 
 
BHens_GR        ------------------------------------------------------------ 
RMeli_GR        ------------------------------------------------------------ 
ChRein_GR2      ------------------------------------------------------------ 
AThal_GR2       MASTPKLTSTISSSSPSLQFLCKKLPIAIHLPSSSSSSFLSLPKTLTSLYSLRPRIALLS 
ChRein_GR1      ------------------------------------------------------------ 
AThal_GR1       ------------------------------------------------------------ 
PFalc_GR        ------------------------------------------------------------ 
SCerv_GR        ------------------------------------------------------------ 
HSapi_GR        MA---------------------LLPRAL—SAGAGPSWRRAARAFRGFLLLLPEPAALT 
SMuta_GR        ------------------------------------------------------------ 
EColi_GR        ------------------------------------------------------------ 
YPest_GR        ---------------------------------------------MTGY----------- 
                                                                             
BHens_GR        -------------------------MGSFDFDLFVIGSGSGGVRAARLAGA-LGKRVAIA 
RMeli_GR        -------------------------MSAFDYDLFVIGGGSGGVRSGRLAAA-LGKKVAIA 
ChRein_GR2      -------------------MASASAGEQFDFDLFTIGAGSGGVRGSRFASS-YGAKVAVC 
AThal_GR2       NHRYYHSRRFSVC---ASTDNGAESDRHYDFDLFTIGAGSGGVRASRFATS-FGASAAVC 
ChRein_GR1      --------------------------MAEEYDLVTLGAGSGGVRASRFAATLYGAKVACV 
AThal_GR1       -----MARKMLVDGEIDKVAADEANATHYDFDLFVIGAGSGGVRAARFSAN-HGAKVGIC 
PFalc_GR        ----------------------------MVYDLIVIGGGSGGMAAARRAAR-HNAKVALV 
SCerv_GR        -------MLSATKQTFRSLQIRTMSTNTKHYDYLVIGGGSGGVASARRAAS-YGAKTLLV 
HSapi_GR        R---ALSRAMACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAE-LGARAAVV 
SMuta_GR        --------------------------MTKQYDYIVIGGGSGGIASANRAAM-HGAKVILF 
EColi_GR        --------------------------MTKHYDYIAIGGGSGGIASINRAAM-YGQKCALI 
YPest_GR        --------------------LMETTLMTKHYDYLAIGGGSGGIASINRAAM-YGKKCALI 
                                              :* ..:*.****: . . :    .       
 
BHens_GR        EE----------YRIGGTCVIRGCVPKKLYFYASQYAQEFS-KSIGFGWKYA-------- 
RMeli_GR        EE----------FRYGGTCVIRGCVPKKLYVYASQFAEHFE-DAAGFGWTVG-------- 
ChRein_GR2      ELPFDYISSDTKGGVGGTCVLRGCVPKKLMVYASEYAEEFK-ASQGFGWTLPP------G 
AThal_GR2       ELPFSTISSDTAGGVGGTCVLRGCVPKKLLVYASKYSHEFE-DSHGFGWKYET------- 
ChRein_GR1      ELPFGFVSSETVGGAGGTCVIRGCVPKKLLVYGAAYAEEFA-DARGFGWALPAAGAGAEG 
AThal_GR1       ELPFHPISSEEIGGVGGTCVIRGCVPKKILVYGATYGGELE-DAKNYGWEINE------- 
PFalc_GR        EK----------SRLGGTCVNVGCVPKKIMFNAASVHDILE-NSRHYG--------FDT- 
SCerv_GR        EA----------KALGGTCVNVGCVPKKVMWYASDLATRVS-HANEYGLYQNLP—LDKE 
HSapi_GR        ES----------HKLGGTCVNVGCVPKKVMWNTAVHSEFMH-DHADYG--------FPSC 
SMuta_GR        EG----------KQVGGTCVNVGCVPKKVMWYGAQVAETINNYAADYG--------FDVT 
EColi_GR        EA----------KELGGTCVNVGCVPKKVMWHAAQIREAIHMYGPDYG--------FDTT 
YPest_GR        EA----------KQLGGTCVNVGCVPKKVMWHAAQIAEAIHLYGPDYG--------FDTT 
                *              *****  ******:    :     .      :*             
 
 
 
BHens_GR        DPIFNWEKLVAAKNKEISRLEGLYREGLQNSNVHIYESRAVFVDEHTLELSV-------- 
RMeli_GR        ESRFDWAKLVAAKEQEIARLEGLYRKGLANAGAEILDTRAELAGPNTVKLLA-------- 
ChRein_GR2      AATHSWTAFIEAKRKELQRLNGAYKNTLKNAKVELVEGRGRVVDAHTVEVDG-------- 
AThal_GR2       EPSHDWTTLIANKNAELQRLTGIYKNILSKANVKLIEGRGKVIDPHTVDVDG-------- 
36 
ChRein_GR1      GPAHDWASLMKLKEKEITRLNSTYGNILKNANVALIEGRGALKDAHTVEVTA-------- 
AThal_GR1       KVDFTWKKLLQKKTDEILRLNNIYKRLLANAAVKLYEGEGRVVGPNEVEVRQ-------- 
PFalc_GR        KFSFNLPLLVERRDKYIQRLNNIYRQNLSKDKVDLYEGTASFLSENRILIKGTKDNNNKD 
SCerv_GR        HLTFNWPEFKQKRDAYVHRLNGIYQKNLEKEKVDVVFGWARFNKDGNVEVQK-------- 
HSapi_GR        EGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTI---------- 
SMuta_GR        TQAFHFDVLKQNRQAYIDRIHDSYERGFDSNGVERVYGYATFVDA—HTV---------- 
EColi_GR        INKFNWETLIASRTAYIDRIHTSYENVLGKNNVDVIKGFARFVDA—KTL---------- 
YPest_GR        VNHFDWKKLIANRTAYIDRIHQSYERGLGNNKVDVIQGFARFVDA—HTV---------- 
                   .    :   :   : *:   * . : .         . .       :           
 
BHens_GR        -T---GERISAEKILIATGAKIVSNS---AIKGSDLCLTSNEIFDLEKLPKSI-VIVGGG 
RMeli_GR        -S---GKTVTAERIVIAVGGHPSPHD---ALPGHELCITSNEAFDLPALPESI-LIAGGG 
ChRein_GR2      ------KRYRAKNILIAVGGKPHK-L---DIPGAELCITSDEALELPACPQKV-AVLGGG 
AThal_GR2       ------KIYTTRNILIAVGGRPFI-P---DIPGKEFAIDSDAALDLPSKPKKI-AIVGGG 
ChRein_GR1      -ADGSVRLLKAKHVLIATGGVATA-I---PMEGAEHAIMSDDALALQSLPPGPIVVLGAG 
AThal_GR1       -IDGTKISYTAKHILIATGSRAQK-P---NIPGHELAITSDEALSLEEFPKRA-IVLGGG 
PFalc_GR        NGPLNEEILEGRNILIAVGNKPVF-P---PVKGIENTISSDEFFNIKES-KKI-GIVGSG 
SCerv_GR        -RDNTTEVYSANHILVATGGKAIF-PE—NIPGFELGTDSDGFFRLEEQPKKV-VVVGAG 
HSapi_GR        --EVSGKKYTAPHILIATGGMPST-PHESQIPGASLGITSDGFFQLEELPGRS-VIVGAG 
SMuta_GR        --EVAGEHYTAPHILIATGGHALL-P---DIPGSEYGITSDGFFELDAIPKRT-AVVGAG 
EColi_GR        --EVNGETITADHILIATGGRPSH-P---DIPGVEYGIDSDGFFALPALPERV-AVVGAG 
YPest_GR        --EVNGETITADHILIATGGRPSH-P---DIPGAEYGIDSDGFFELDEMPKRV-AVVGAG 
                            .:::*.*           : * .    *:  : :         : . 
 
BHens_GR        YIGVEFANIFHGLGV---KTTLLHRGDLILRNFDYDLRQLLNDAMVAKGISIIYEATVSQ 
RMeli_GR        YIAVEFANIFHGLGV---KTTLIYRGKEILSRFDQDMRRGLHAAMEEKGIRILCEDIIQS 
ChRein_GR2      YIAVEFAGIFSRFGA---EVHTVYRQPLPLRGFDEEVRKFAAEQYAAAGLHLHAGCNPVS 
AThal_GR2       YIALEFAGIFNGLNC---EVHVFIRQKKVLRGFDEDVRDFVGEQMSLRGIEFHTEESPEA 
ChRein_GR1      YIATEFAGIFRGTHAAQYAVHLMFRGDKVLRGFDEECRDQVQDNLTRRGIHLHPGCKPTK 
AThal_GR1       YIAVEFASIWRGMGA---TVDLFFRKELPLRGFDDEMRALVARNLEGRGVNLHPQTSLTQ 
PFalc_GR        YIAVELINVIKRLGI---DSYIFARGNRILRKFDESVINVLENDMKKNNINIVTFADVVE 
SCerv_GR        YIGIELAGVFHGLGS---ETHLVIRGETVLRKFDECIQNTITDHYVKEGINVHKLSKIVK 
HSapi_GR        YIAVEMAGILSALGS---KTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKE 
SMuta_GR        YIAVEISGILHALGS---ETHLFVRRDRPLRKFDKEIVGTLVDEMKKDGPHLHTFSVPKE 
EColi_GR        YIAVELAGVINGLGA---KTHLFVRKHAPLRSFDPMISETLVEVMNAEGPQLHTNAIPKA 
YPest_GR        YIAVEIAGVLNGLGT---ETHLFVRKHAPLRTFDPLIVETLLEVMNTEGPKLHTESVPKA 
                **. *: .:             . *    *  **              .  .         
 
BHens_GR        VQSTENCYNVV-L--------TNGQTICADRVMLATGRVPNTTGLGLERAGVKVNEFGAV 
RMeli_GR        VSADADGRRVATT--------MKHGEIVADQVMLALGRMPNTNGLGLEAAGVRTNELGAI 
ChRein_GR2      VSKQPNGKLSLVVKGPDG---ATSTLTDLDQVMMATGRVPKTSGLGLEEAGVKMGSKGQV 
AThal_GR2       IIKAGDGSFSLKT--------SKGTVEGFSHVMFATGRKPNTKNLGLENVGVKMAKNGAI 
ChRein_GR1      LEKHGEGDLTLHYTDGTG---AAQ-SLKCGLVMMATRRKPRVDGIGLEAVGVALDGQGAI 
AThal_GR1       LTKTDQGIKVISS--------HGE-EFVADVVLFATGRSPNTKRLNLEAVGVELDQAGAV 
PFalc_GR        IKKVSDKNLSIH-------LSDGRIYEHFDHVIYCVGRSPDTENLKLEKLNVETN-NNYI 
SCerv_GR        VEKNVETDKLKI------HMNDSKSIDDVDELIWTIGRKSH-LGMGSENVGIKLNSHDQI 
HSapi_GR        VKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHI 
SMuta_GR        VIKNTDNSLTLIL--------ENGEEYTVDTLIWAIGRAANTKGFNLEVTGVTLDSRGFI 
EColi_GR        VVKNTDGSLTLEL--------EDGRSETVDCLIWAIGREPANDNINLEAAGVKTNEKGYI 
YPest_GR        VIKNADGSLTLQL--------ENGTEVTVDHLIWAIGREPATDNLNLSVTGVKTNDKGYI 
                :    .                       . ::    *      :  .  .:     . : 
 
BHens_GR        VVDEKMTTNVSHIWAVGDVTG----------------------------------HIQLT 
RMeli_GR        IVDAFSRTSTPGIYALGDVTD----------------------------------RVQLT 
ChRein_GR2      LVDEYCRTNVPSIWAVGDVID----------------------------------RIQLT 
AThal_GR2       EVDEYSQTSVPSIWAVGDVTD----------------------------------RINLT 
ChRein_GR1      KVDEFSRTNVPDVWAIGDVTN----------------------------------RINLT 
AThal_GR1       KVDEYSRTNIPSIWAVGDATN----------------------------------RINLT 
PFalc_GR        VVDENQRTSVNNIYAVGDCCMVKKSKEIEDLNLLKLYNEERYLNKKENVTEDIFYNVQLT 
SCerv_GR        IADEYQNTNVPNIYSLGDVVG----------------------------------KVELT 
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HSapi_GR        IVDEFQNTNVKGIYAVGDVCG----------------------------------KALLT 
SMuta_GR        ATDAFENTNVEGLYALGDVNG----------------------------------KLELT 
EColi_GR        VVDKYQNTNIEGIYAVGDNTG----------------------------------AVELT 
YPest_GR        EVDKFQNTNVKGIYAVGDNTG----------------------------------VVELT 
                 .*    *.   ::::**                                        ** 
 
BHens_GR        PVAIHDAMCFVKNAFENT---STTPDYDLITTAVFSQPEIGTVGLSEEDALHRY-K-RVE 
RMeli_GR        PVAIHEAMCFIETEYKNN---PTSPDHDLIATAVFSQPEIGTVGITEEEAARKF-Q-EIE 
ChRein_GR2      PVALMEGMAVAKSVAHNT---PTVPDYFAVPSAVFSNPEIATVGYSEEQAAEKY-G-DVD 
AThal_GR2       PVALMEGGALAKTLFQNE---PTKPDYRAVPCAVFSQPPIGTVGLTEEQAIEQY-G-DVD 
ChRein_GR1      PVALMEGMAFAKSCFGGE---LTKPDYRNVASAVFCQPPLATVGYTEEQAVKEFAG-NID 
AThal_GR1       PVALMEATCFANTAFGGK---PTKAEYSNVACAVFCIPPLAVVGLSEEEAVEQATG-DIL 
PFalc_GR        PVAINAGRLLADRLFLKK---TRKTNYKLIPTVIFSHPPIGTIGLSEEAAIQIYGKENVK 
SCerv_GR        PVAIAAGRKLSNRLFGPEKFRNDKLDYENVPSVIFSHPEAGSIGISEKEAIEKYGKENIK 
HSapi_GR        PVAIAAGRKLAHRLFEYK—EDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVK 
SMuta_GR        PVAVKAGRQLSERLFNHK—PQAKMDYKDVATVIFSHPVIGSIGLSEEAALDQYGEENVT 
EColi_GR        PVAVAAGRRLSERLFNNK—PDEHLDYSNIPTVVFSHPPIGTVGLTEPQAREQYGDDQVK 
YPest_GR        PVAVAAGRRLSERLFNNK—PDEHLDYSNIPTVVFSHPPIGTIGLTEPQAREKFGDDQVK 
                ***:  .  . .             ::  :  .:*. *  . :* :*  *        :  
 
BHens_GR        IYRTVFRPMRNVLSG----SPEKMFMKLVVDGESRIVVGAHVLGENAGEIAQLIGISLKG 
RMeli_GR        VYRAEFRPMKATLSG----RKEKTIMKLVVNAADRKVVGAHILGHDAGEMAQLLGISLRA 
ChRein_GR2      IYTTSFKPMRNTISG----SPIRTFMKIVVDAASQKVVGMHMVGAEAAEIMQGFAVAVKV 
AThal_GR2       VYTSNFRPLKATLSG----LPDRVFMKLIVCANTNKVLGVHMCGEDSPEIIQGFGVAVKA 
ChRein_GR1      VYVSRFRPMKYTISG----REEKTLMKLIVHAESDVVLGCHMVGPDAPEIMQGLAVALKC 
AThal_GR1       VFTSGFNPMKNTISG----RQEKTLMKLIVDEKSDKVIGASMCGPDAAEIMQGIAIALKC 
PFalc_GR        IYESKFTNLFFSVYDIEPELKEKTYLKLVCVGKDELIKGLHIIGLNADEIVQGFAVALKM 
SCerv_GR        VYNSKFTAMYYAMLS----EKSPTRYKIVCAGPNEKVVGLHIVGDSSAEILQGFGVAIKM 
HSapi_GR        TYSTSFTPMYHAVTK----RKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKM 
SMuta_GR        VYRSTFTSMYTAVTS----HRQACKMKLVTVGEDEKIVGLHGIGYGVDEMIQGFAVAIKM 
EColi_GR        VYKSSFTAMYTAVTT----HRQPCRMKLVCVGSEEKIVGIHGIGFGMDEMLQGFAVALKM 
YPest_GR        VYTSSFTAMYSAVTQ----HRQPCRMKLVCVGAEEKIVGIHGIGFGMDEILQGFAVAMKM 
                 : : *  :   :             *::       : *    *    *: * :.::::  
 
BHens_GR        KLTKDIFDKTMAVHPTMSEELVTMYKPSYVYENGEKLDN----------- 
RMeli_GR        GCTKDDFDRTMAVHPTAAEELVTMYQPSYRVRNGERVG------------ 
ChRein_GR2      GATKQQLDSVVGIHPSAAEEFVTMRTVSRQVRKPA--------------- 
AThal_GR2       GLTKADFDATVGVHPTAAEEFVTMRAPTRKFRKDSSEGKASPEAKTAAGV 
ChRein_GR1      GATKAQFDSTVGIHPTAAEEFVTMRSRSRRVPATGTSKL----------- 
AThal_GR1       GATKAQFDSTVGIHPSSAEEFVTMRSVTRRIAHKPKPKTNL--------- 
PFalc_GR        NATKKDFDETIPIHPTAAEEFLTLQPWMK--------------------- 
SCerv_GR        GATKADFDNCVAIHPTSAEELVTMR------------------------- 
HSapi_GR        GATKADFDNTVAIHPTSSEELVTLR------------------------- 
SMuta_GR        GATKADFDNTVAIHPTGSEEFVTMR------------------------- 
EColi_GR        GATKKDFDNTVAIHPTAAEEFVTMR------------------------- 
YPest_GR        GATKKDFDNTVAIHPTAAEEFVTMR------------------------- 
                  **  :*  : :**: :**::*:    
 
A colon (:) in a sequence alignment indicates conservative mutations meaning that even 
if the exact amino acid is not conserved the biochemical properties stays similar (like 
hydrophobicity, charge or size). An asterisk (*) indicates conserved sequence. For various 
GRs, quite a few primary structure characteristics are sustained, such as cysteines, 
glycines, serines, prolines, etc. In an alignment, there are few peptides maintaining the 
same order being likely binding pockets for nucleotides. A single dot (.) is a semi-
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conservative mutation and no sign simply means non-conservative mutation. As indicated 
above conservative mutations are rather abundant and the majority has strongly 
hydrophobic character. Protein identity with GR1 and accession codes is shown in Table 
2. 
Table 2. Summary of GR identity with different origin enzymes that are available on Uniprot and/or PDB 
database. In green is highlighted best identity of available structure, and in yellow the identity with 
homologous plant organism (while the structure is not known). 
Organism Uniprot ID PDB ID Identity GR1 Identity GR2 
Chlamydomonas reinhardtii (GR1) A8HXA6 - - 51.497% 
Homo sapiens P00390 3DK9 29.359% 24.064% 
Plasmodium falciparum Q94655 1ONF 26.802% 18.761% 
Saccharomyces cerevisiae P41921 2HQM 32.819% 24.539% 
Streptococcus mutans Q8DUR5 5V36 34.073% 35.331% 
Escherichia coli P06715 1GER 34.879% 24.811% 
Yersinia pestis Q8CZL0 5VDN 33.992% 39.095% 
Bartonella henselae A0A0H3LWY9 3O0H 36.97% 28.729% 
Rhizobium meliloti Q92PC0 4DNA 40.202% 28.281% 
Arabidopsis thaliana (GR1) P48641 - 50.969% 47.431% 
Arabidopsis thaliana (GR2) P42770 - 43.441% 49.037% 
 
Not surprisingly the highest identity is observed for those belonging to the plant kingdom 
(Arabidopsis thaliana) with values around 50%. In the case of those GRs that are 
accessible on PDB, identity is lowered to ~40%. In fact, those with known structures are 
helpful in phase problem solving with molecular replacement. Since the threshold limit for 
MR is ~30% sequence identity there are technically six possible model structures. 
 
 4.3 Crystallization trials and optimization 
Once the pure and homogenous sample of protein was obtained crystallization 
trials were performed. Both isoforms were at concentration of 10 mg/mL in  30 mM Tris-
HCl (pH 7.9) and 1 mM EDTA. The screening kit from Molecular Dimensions Structure 
Screen 1 cacodylate free MD1-01-CF was utilized and for GR1 all 50 conditions were 
tested while due to volume limitation of GR2 only 24 conditions were taken into account. 
Conditions for GR2 were picked as an educated guess from the existing crystallization 
conditions for GR from various organisms. 
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Plates were kept in the protein incubator at 20 ± 1 °C and regularly checked under the 
polarized microscope every seven days. After two weeks few positive results were 
observed for GR1, with varying size and morphology of the crystals (Figure 14). In the 
case of GR2, the majority of the drops remained clear for about two months,  indicating 
that the starting protein concentration was not sufficient to reach the supersaturation 
conditions. The most probable explanation is an inaccurate determination of protein 
concentration after the purification procedure. The only crystals and spherulites grown are 
shown in Figure 15. 
 
Figure 15. Images of positives hints for GR2. Due to the size and morphology of the crystals, they were not 
considered in further analysis. Labels and scale bar as in Figure 14. 
Figure 14. Images of positives hints from crystallization trials for GR1. All images taken at zoom 4x under 
polarized light. Naming scheme: plate#/well/reagent solution. 70µm scale bar located at every top left 
corner. 
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Crystallization trials gave 10 positive results after only 2 weeks. With this number, it was 
possible to efficiently design the optimization step. Most promising results were observed 
for I/C3/33 giving single crystals with well-defined faces, quite large variety of 
morphologies, and uniform size distribution (around 100 µm each). A similar observation 
was valid for I/C6/37 in terms of size distribution. Several conditions gave quite large 
crystal aggregates as I/B4/20, I/C2/31, and I/C2/31, while from conditions I/A4/7 and 
I/B1/15 branched crystalline aggregates grew. The list of the reservoir solution 
composition is reported in Table 3.  
Table 3. List of reagent solutions for crystallization trials that gave positive results. In green are marked 
reservoir solutions given priority in optimization step. 
N° Image code Salt Buffer (pH) Precipitant 
1 I/A4/7 0.2 M ammonium acetate 
0.1 M tri-sodium citrate 
(5.6) 
30% w/v PEG 4 kDa 
2 I/B1/15 0.2 M magnesium acetate 0.1 M MES (6.5) 20% w/v PEG 8 kDa 
3 I/B2/18 0.2 M sodium acetate 0.1 M MES (6.5) 30% w/v PEG 8 kDa 
4 I/B4/20 0.2 M calcium acetate 0.1 M MES (6.5) 18% w/v PEG 8 kDa 
5 I/C2/31 None 0.1 M Na HEPES (7.5) 
10% v/v 2-propanol, 
20% w/v PEG 4 kDa 
6 I/C3/33 0.2 M magnesium chloride 0.1 M Tris (8.5) 30% w/v PEG 4 kDa 
7 I/C6/37 0.2 M sodium acetate 0.1 M Tris (8.5) 30% w/v PEG 4 kDa 
8 I/D4/46 
0.05 M potassium 
dihydrogen phosphate 
None 20% w/v PEG 8 kDa 
9 I/D5/47 None None 30% w/v PEG 8 kDa 
10 II/D1/32 None 0.1 M Tris (8.5) 
2.0 M ammonium 
sulfate 
 
The table indicates that the best precipitant for GR1 is a polymer as PEG with a molecular 
weight of 4 or 8 kDa. Improved morphology and size distribution can be observed at a 
smoothly elevated pH (8.5 for N° 6 and 7) using Tris buffer and high concentration of PEG 
4 kDa. When inspecting a salt present in the solution no visible trend is observed since 
even in cases lacking salt (N° 5, 9 and 10) crystals were formed. Also, N° 3 and 9 were 
considered to be encouraging targets for crystal form improvement. 
For the optimization step, 68 conditions were primarily planned with protein at the same 
concentration as for the trials. For these experiments, several conditions from two extra 
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kits were employed (Crystal Extension Kit and JCGS-plus, reagent composition list in 
additional information) with 20 solutions prepared manually. Main parameters that were 
adjusted are: 
• Precipitant concentration and its molecular weight - Polyethylene glycol with a 
molecular    weight between 3.350 and 8 kDa in concentration range 18 – 30% w/v 
was utilized; 
• pH – certain conditions with lower pH were taken for optimization to see the 
influence of those below 8.5 (here 6.5 and 7.5); 
• Salts – no striking conclusions were withdrawn here, thus most commonly used 
salts were tested (like magnesium chloride, ammonium sulfate, 
sodium/calcium/ammonium acetate or none);  
Three weeks were required to observe a positive results. Optimization step can be 
considered successful. As seen in Figure 16 there are conditions where modifications 
applied lead to the growth of single, clean-face crystals with dimensions suitable for an 
XRD experiment as for condition III/C6/33B in which a unique single crystal with dimension 
270 µm in every direction, was observed. Thus, conclusions withdrawn about precipitant 
concentration and molecular weight were correct. Table 4 contains reagent solution 
composition for positives indicating that magnesium chloride, Tris buffer at pH 8.5 and a 
decrease in PEG 4 kDa concentration (from 30% w/v down to 20% w/v) was the best 
crystallization condition. Also, condition with 25% w/v PEG 4 kDa (III/C6/33A, Figure 16) 
resulted in clean morphology crystals of lower dimensions. 
Even though conditions N° 7 and 8 gave the best result, more crystals were fished in the 
case of unexpected events (such as weakly diffracting crystals). Precisely 29 crystals were 
taken for an XRD experiment at synchrotron radiation source. Before freezing in liquid 
nitrogen, each crystal was fished with a loop of an appropriate size and immersed in a 
solution containing the original precipitant concentration plus  20% w/v PEG 400 Da used 
as a cryoprotectant. 
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Figure 16. Images of positives from optimization step for GR1. All images taken at zoom 4x under polarized 
light. Naming scheme: plate#/well/reagent solution. 70 µm scale bar located at every top left corner. 
 
Table 4. List of reagent solutions for optimization step that gave positive results. In yellow marked reagent 
solutions that gave suitable crystals for an XRD analysis. 
N° Image code Salt Buffer (pH) Precipitant 
1 III/A5/18B 0.2 M sodium acetate 0.1 M MES (6.5) 18% w/v PEG 4 kDa 
2 III/B1/18C 0.2 M magnesium chloride 0.1 M MES (6.5) 18% w/v PEG 8 kDa 
3 III/B2/18D 0.2 M magnesium chloride 0.1 M MES (6.5) 18% w/v PEG 4 kDa 
4 III/B4/20 0.2 M calcium acetate 0.1 M MES (6.5) 18% w/v PEG 8 kDa 
5 III/C3/33 0.2 M magnesium chloride 0.1 M Tris (8.5) 30% w/v PEG 4 kDa 
6 III/C4/37 0.2 M sodium acetate 0.1 M Tris (8.5) 30% w/v PEG 4 kDa 
7 III/C5/33A 0.2 M magnesium chloride 0.1 M Tris (8.5) 25% w/v PEG 4 kDa 
8 III/C6/33B 0.2 M magnesium chloride 0.1 M Tris (8.5) 20% w/v PEG 4 kDa 
9 V/C1/1-42 
0.2 M magnesium chloride 
hexahydrate 
0.1 M Tris (8.5) 20% w/v PEG 8 kDa 
10 V/C2/1-45 0.17 M ammonium sulfate None 
25.5% w/v PEG 4 kDa, 
15% w/v glicerol 
11 V/D1/2-46 0.2 M ammonium acetate 0.1 M BIS-Tris (5.5) 
25% w/v PEG 3.35 
kDa 
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 4.4 Data collection, processing and model building 
 4.4.1 Data collection 
Out of 29 crystals prepared for XRD analysis at ESRF, for 11 crystals full data set 
was collected. Other crystals were not taken for full data collection due to centering issues, 
weak diffraction or simply time limitation. Nevertheless, software for data collection at 
ID23.1 beamline gives a primary estimate about the resolution or more generally the 
quality of the data based on diffraction pattern. The best resolution of 1.713 Å and  2.109 
Å was observed for III/C6/33B crystal and III/C5/33A respectively. The image of a centered 
and mounted crystal with an exemplary diffraction pattern is shown in Figure 17. 
 
Experimental details from the data collection and processing for III/C6/33B sample are 
summarized in Table 5. Preliminarily processed data is available right after the diffraction 
experiment and is accessible on ISPyB website (Information System for Protein 
crystallography Beamlines for ESRF, SOLEIL, MAXIV and few EMBL beamlines). Some 
data processing is fully automatic, hence indexing (assigning Miller indices for each 
reflection and the Bravais lattice, determining the unit cell parameters), merging and 
scaling  (to merge the reflections related to the same symmetry operations and assigning 
the space group) and structure factor (Fhkl) that is calculated from the intensities of a 
diffraction spot. 
Figure 17. Left: images of III/C6/33B crystal manually centered on a goniometer. Right: exemplary 
diffraction pattern of a GR1 crystal taken for a full data collection. 
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Table 5. Summary of data collection, refinement and Ramachandran plot details for the III/C3/33B sample. 
Parameter CrGR1 
Data collection 
Unit cell 
a=77.5 Å, b=99.7 Å, c=107.8 Å, α= 90°, 
β=90°, γ=90° 
Space group P 21 21 21 
Resolution range* (Å) 73.215-1.713 Å (1.743-1.713 Å) 
Unique reflections 59484 
Completeness* (%) 100.0 (99.2) 
Rmerge* 13.0 (108.9) 
I/σ 13.9 (2.2) 
Multiplicity 12.7 (13.3) 
Refinement 
Resolution range* (Å) 73.21 - 1.71 (1.758-1.713) 
Reflection used 85749 (6240) 
R/Rfree* % 19.49/24.4 
rmsd from ideality (Å, °) 0.021, 2.209 
Non-hydrogen atoms 7830 
Protein atoms 7342 
Water molecules 438 
B value (Å2) 
Mean (chain A and B) 28.081 
Solvent molecules 30.00 
Ramachandran plot (%) 
Most favored 94.88 
Allowed 3.38 
Outliers 1.74 
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 4.4.2 Choice of the best model and resolution 
Once the full set of data was collected, main output parameters were evaluated to 
find the most representative data in terms of statistics. In that case overall resolution 
estimate, completeness, I/σ, and shell multiplicity are crucial. The choice here would mean 
picking the best data for further processing and again the data collected for III/C6/33B 
were found to be of an excellent quality compared to others. Then mtz file containing the 
amplitudes of structure factors and errors was extracted and taken for structure 
determination procedures. From the experimental data, it is possible to guess the 
asymmetric unit content by calculating the Mattews coefficient and the solvent content. 
For GR1 the value of the Mattews coefficient equal to 2.32 indicates that a whole dimer is 
contained in the asymmetric with a solvent content of 47%.    
As mentioned in the previous chapter a lot of information is automatically processed, 
including the structure factor Fhkl. During an XRD experiment, the information about the 
phase of a diffracted beam is lost, meaning there is no way to assign the origin the wave 
itself.  
Molecular replacement was chosen as 
the first attempt for the phase problem 
solution. This approach is possible when 
homologous protein is available in PDB 
(thus with at least 30-35% identity). Here 
this is the case since quite few protein 
structures are reported for GR. As a first 
shot the GR with the best identity (~40%) 
was taken for structure determination - 
Sinorhizobium meliloti (PDB ID: 4DNA, 
Uniprot: Q92PC0). One protein chain 
deprived of ligand and water molecules 
was used. The calculations gave two 
solutions, corresponding to two protein chains, thus a whole dimer, in the asymmetric unit 
as indicated by the Mattews coefficient (unit cell packing shown in Figure 18). At the first 
sight the model seemed to be working to some extent, but unfortunately, after few 
Figure 18. Unit cell packing for GR2. The neighboring 
proteins did not show clashes, hence molecular 
replacement worked properly. 
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attempts, there were regions with difficult-
to-identify densities and the refinement 
calculations stacked. Another problem that 
appeared was the chain length. The 
difference of thirty amino acids (model had 
463 residues while GR1 has 493) made it 
difficult in the model building at the C-
terminal end.  
Thus, the structure of GR from 
Saccharomyces cerevisiae (PDB ID: 
2HQM, Uniprot: P41921) deprived of ligand and water molecules, was taken as a model 
for the second molecular replacement attempt. Its identity with GR1 was 32% but the 
chain length was 473 residues. Thus it was a convenient solution in terms of fitting amino-
acids into the density, and no unassigned  electron densities were observed. Resolution 
better than 2 Å simplifies the work in terms of the model building because all residues can 
be distinguished as in Figure 19 where the flavin ring of a FAD nucleotide exhibit clear, 
assignable density. Final refinement statistics are reported in Table 5.  
The resolution determines the quality of the electron density, final structure and the 
resolution itself is purely dependent on the quality of the crystal. 
 
 4.5 FAD binding pocket and comparison with pro- and eukaryotic organisms 
Final resolution of the Chlamydomonas reinhardtii GR was 1.7 Å allowing for 
reliable structural insights. GR is a homodimer employing FAD and NADPH to efficiently 
convert one molar equivalent of GSSG into two equivalents of GSH. The schematic 
mechanism is based on proton donation/acceptance as presented in introduction chapter. 
The enzymatic mechanism of GR is of ping-pong type and is connected to reductive and 
oxidative half reaction.  
Redox chemistry involved in GRs enzymatic activity has certain well-conserved residues, 
such as histidines and cysteines. Understanding flavoenzymes — enzymes using FAD in 
catalysis — is particularly complex because of flavin’s involvement in a wide variety of 
chemical reactions and its possible redox and protonation states, each of which has 
Figure 19. 2F0-Fc  electron density map contoured at 
1σ around FAD region. Visualized with Coot. 
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unique properties and can be stabilized or destabilized by the protein environment. [32] A 
comparative study of three-dimensional structures and sequences stands for a good 
indication of evolutionary pathways. Even though GR is an extensively studied enzyme 
there was no single plant-origin structure available and this is probably the first attempt in 
comparing protein-ligand interactions for GR from five kingdoms representatives, being: 
I. Plantae - Chlamydomonas reinhardtii 
II. Animalia - Homo Sapiens 
III. Fungi - Saccharomyces cerevisiae 
IV. Protista - Plasmodium falciparum 
V. Bacteria - Rhizobium meliloti 
Where in yellow are highlighted eukaryotic organisms and in blue prokaryotic. This group 
of organisms could be considered complete family around ten years ago. Pace et al. 
(2006) in his paper Time for change (Nature) [34] classified Archaea as a distinct kingdom, 
thus we should include one more prokaryotic kingdom. Yet it can be considered a 
representative set of structures. In terms of interactions of the flavin with the neighboring 
residues the most interesting ones include tyrosine, cysteine disulfide bond, and histidine 
since the first is responsible for accommodation of NADPH (as stated in the introduction 
- tyrosine is a ‘gate-keeper’), cysteines are here important in terms of histidine 
protonation/deprotonation steps that further facilitate conversion of GSSG into GSH. 
The main difficulty in structural studies of enzymes employing many 
protonation/deprotonation steps is the resolution. Even structures at 0.95 Å do not provide 
for example protonated state of the histidine. [33] The proceeding subchapters present 
graphically interaction of FAD with its environment with highlighted distances. 
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 4.5.1 Plantae - Chlamydomonas reinhardtii 
The resolved structure of plant origin 
GR shows well conserved structural 
features. The FAD pocket shows a 
Rossman fold characteristic of 
proteins that bind nucleotide as 
NAD+, NADP+ or FAD. In GR1 is 
formed by parallel β sheets and 5 α 
helices. The first β-strand is followed 
by a tight loop that is connected to 
the N-terminal of the helix. The two 
highly conserved Gly residues in the  
sequence are located in this turn to 
allow the sharp bending of the chain. 
At the end of the helix there is a 
wider turn that is followed by the 
second beta strand that runs parallel 
to the first strand. Here the Rossman 
fold holding FAD molecule is 
stabilized by same hydrophobic side 
chains. Also, those involved in 
catalytic activity seems to have very 
similar spatial orientation compared 
to other GRs as can be seen in 
Figure 20. 
 
 
 
 
 
 
Figure 20. Image A: ligand interaction with neighboring 
residues and hydrogen bonds distances. Image B: three 
dimensional view on FAD binding pocket with highlighted 
catalytic cysteines (yellow), histidine (cyan), and tyrosine 
(brown). 
A 
B 
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 4.5.2 Animalia – Homo Sapiens 
Animal origin GR was actually 
the first GR resolved. It gives 43 
hits in PDB (including 
transferases, nitroso-GRs, 
carbonyl-GRs and 
hydroquinones) database. In 
this study the best resolution 
GR was taken (0.95 Å). Figure 
21 presents two-dimensional 
view on FAD binding pocket 
with hydrophobic residues and  
the three dimensional 
representation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
Figure 21. Image A: ligand interaction with neighboring residues 
and hydrogen bonds distances. Image B: three dimensional view on 
FAD binding pocket with highlighted catalytic cysteines (yellow), 
histidine (cyan), and tyrosine (brown). Accession code: 3DK9. 
B 
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 4.5.3 Fungi - Saccharomyces cerevisiae  
Fungi GR is one of the few 
resolved structures 
accessible on PDB and was 
resolved at 2.4 Å. The first 
yeast structure was reported 
in 2007 under PDB ID: 
2HQM. Figure 22 presents 
neighboring residues 
interaction in two- and three 
dimensions respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Image A: ligand interaction with neighboring residues and 
hydrogen bonds distances. Image B: three dimensional view on FAD 
binding pocket with highlighted catalytic cysteines (yellow), histidine 
(cyan), and tyrosine (brown). Accession code: 2HQM. 
A 
B 
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 4.5.4 Protista - Plasmodium falciparum 
Protista GR representative 
shown here in Figure 23 and  
comes from structure 
resolved at 2.6 Å in 2003 
with accession code 1ONF 
on PDB.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Image A: ligand interaction with neighboring residues and 
hydrogen bonds distances. Image B: three dimensional view on FAD 
binding pocket with highlighted catalytic cysteines (yellow), histidine 
(cyan), and tyrosine (brown). Accession code: 1ONF. 
A 
B 
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 4.5.5 Bacteria - Rhizobium meliloti 
Bacterial GR is 
extensively studied 
enzyme and most 
popular species 
would be E. Coli but 
highest identity with 
plant structure was 
observed for R. 
Meliloti. Again 
without a surprise 
many residues 
maintain similar 
orientation around 
FAD nucleotide and 
are presented on 
Figure 24. This 
structure was 
obtained at 2.8 Å 
resolution and 
submitted to PDB in 
2012 with an 
accession code 
4DNA. 
 
 
 
 
 
 
 
Figure 24. Image A: ligand interaction with neighboring residues and hydrogen 
bonds distances. Image B: three dimensional view on FAD binding pocket with 
highlighted catalytic cysteines (yellow), histidine (cyan), and tyrosine (brown). 
Accession code: 4DNA. 
A 
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 4.5.6 Structural superimposition 
The conclusion withdrawn from the catalytic site comparison among various origin 
GRs is that they are very well conserved. Thus the question arise, where the difference in 
identity come from. In order to compare the whole structure of different GRs, a 
superimposition of Cα atoms was performed. Figure 25 presents the superimposition of 
Chlamydomonas reinhardtii GR1 with human GR and bacterial GR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Red: C. reinhardtii  GR 
Blue: H. sapiens GR 
r.m.s.d. 1.22 Å 
Green: C. reinhardtii GR  
Orange: E. coli GR 
r.m.s.d. 1.39 Å 
Figure 25. Structural alignment of single GR subunits. (A) Plant and human GR. (B) Plant and bacterial GR. 
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Hence while looking at root mean square deviations (r.m.s.d.) and conservation of the 
secondary structure elements it is seen that they are spatially related, while in plant and 
bacterial subunit differences are more pronounced. Loops are the regions that contribute 
substantially to the identity difference, as being regulatory elements in many enzymes. 
Many loops are exposed to the outer environment in a cell and/or the interface in dimers. 
For GRs probably both aspects contribute notably, what was observed at the model 
building step. The electron densities in such regions are of lower quality in majority of the 
cases, meaning they are not rigid fragments (even in the crystal). This dynamic behavior 
along with chain length differences account for visible difference in both structure and 
protein identity. 
 
 4.6 Conclusions 
Despite the extensive enzymatic and structural studies of GR catalysis, 
uncertainties remain that more detailed pictures of catalysis might resolve. For example, 
in the human GR native structure determined at 1.54 Å resolution, marginally reliable 
deviations in peptide planarity of the active-site disulfide loop were suggested to indicate 
strain that would favor disulfide reduction, as reported by Berkholz et al. (2008). Slight 
deviations in flavin geometry were suggested as possible evidence as to how the protein 
modulates flavin reactivity. Also, the more accurate determination of the geometry of the 
nicotinamide-flavin approach provided by atomic-resolution analysis would help in better 
understanding of the hydride transfer step. Finally, the atomic-resolution analysis could 
yield additional insight by providing a direct visualization of the protonation states of the 
active site Cys and His residues at various stages of catalysis.  
High-resolution structure determination is also essential for precise mechanism 
assessment because as stated in the report by Weik et al. (2000) synchrotron radiation 
can cause specific structural changes such as the cleavage of disulfide bridges and 
reduction of active site metallocenters. This has one advantage of providing a view of 
catalytically relevant reduced enzyme forms that can allow insights into enzyme 
mechanism. But on the other hand, some groups state that radiation-induced reduction 
differs from those naturally reduced enzymes thus taking away valuable information in 
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terms of the geometry of catalytic sites. One of the solutions would be an attempt with 
NMR studies or hydrogen/deuterium exchange experiment. 
For plant glycolytic GR most of the Rossman fold features are conserved even if the 
sequence alignment does not exceed 41% with any other GR available. The FAD-binding 
pocket and its catalytic residues, being His468B, Cys53A and Cys58A are shown in Figure 
20. 
Very interesting observation is made while studying the mechanisms and ping-pong type 
behavior of NAPDH. Literature, in this field, is not very consistent, since some reviews 
state that those are very clear, while the other groups are very uncertain about structural 
features. The proton donor (NADPH) enters and leaves its site many times during catalytic 
cycle as described in Introduction (redox half-reactions). On PDB only one group (at least 
to the author's knowledge) reported NADPH state of GR of human origin (PDB ID: 3DJG). 
This opens up many possibilities in the determination of catalytically active steps structural 
changes.  Reduction of GSSG disulfide involves few protonation and deprotonation steps, 
a formation of charge transfer complex, proton donor exchange, and all in assistance of 
neighboring residues affecting the kinetics of the SN2 reaction.  
Last but not least concern is more general thought on how many molecules of GSSG are 
bound at once to the GR? One would say, two since GR is a homodimer and hence has 
two catalytic sites. Considering complexity of this process it is not becoming very clear, 
whether one GSSG is bound at a time and then after release of two GSH molecules, 
second site becomes available for the new reaction? This and few others become truly 
interesting directions in the flavoenzymes research.  
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 4.6.1 Perspectives 
Compared to available structures of GR the resolution of 1.7 Å can be considered 
a good achievement and also motivation for the continuation of this project. There are 
certain possibilities of expanding this study by determining the structure with NADP+ and 
NAPDH state of the enzyme. Structure with reducing NAPDH would also grant some 
dynamic insights about Tyr201 and its behavior upon nucleotide binding. 
At this stage, having steady protocols for GR1 crystallization, it is possible to start 
crystallization process with other cofactors. Figure 26 presents successful crystallization 
conditions of plant GR1 with NADP+, NADPH and TCEP (a phosphine commonly used for 
disulfides reduction). Those are likely going to be taken for XRD analysis at synchrotron 
radiation source. The morphology of the crystals, as being seed-like shaped, will be 
probably little improved after minor optimizations. Each of those has to be crystallized 
separately to avoid catalytic activity. Another idea for the project is to co-crystallize GR 
with GSH and GSSG without NADPH to identify the affinity of each subunit for glutathione 
binding. Difficult to guess the how successful this would be, hence complementary 
techniques will need to be employed (such as molecular docking). 
Figure 26. GR1 crystals. From the top left corner: first two images are GR1 with NADP+, next three images 
are GR1 reduced with NAPDH, next four images are GR1 with TCEP and remaining two are GR1 with 
NAPDH and TCEP. White scale bar in every corner has approximate length of 70 µm. 
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PROJECT2 
 
Chapter 5 - Introduction 
 5.1 Importance of BODIPY fluorescent probes 
Live cell imaging had become fascinating research area in the light of advanced 
microscopic techniques recently developed. Fluorescence microscopy is an integral part 
of cell biology and the number of tools for tagging and imaging is constantly increasing. 
Nevertheless, in cell imaging there are few challenges difficult to overcome, that is 
minimizing photodamage of the emitting probe, keeping fair signal-to-noise ratio, 
maintaining physiological conditions in the living cell to study dynamics in a stable 
environment and notably choice of the fluorescent probe. [35] 
Fluorescent probes as being available in hundreds, if not thousands, still have properties 
that generate a number of issues when it comes to imaging of biological matter. Recently 
developed boron-dipyrromethene (BODIPY) family of fluorescent dyes have excellent 
photophysical properties and gained recognition in chemistry, molecular biology, and 
physics. Ease of tuning and hence shifting the emission spectra is one of the numerous 
advantages of this class of compounds. 
 
 5.1.1 Fluorescent probes in cell imaging 
Modern cell biology aims at studying dynamic processes within the living cell, such 
as signaling, cellular excitability (i.e. receptors), growth and/or metabolic processes. This 
requires set of tools that can effectively provide a valuable information. Cell dynamics is 
not a trivial target, it requires temporal resolution in both photometric and image data. 
Experimentally there are two aspects to be considered, that is sample preparation and 
design of the fluorescent probe.  
Ultimately the objective is to have a molecule that targets a region of a cell and gives 
visible emission under irradiation with light as a stimulus. In very few cases intrinsic probes 
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can be informative since their location is rather specific and may give a solid signal, for 
instance, NADH, flavins, and porphyrins –  endogenous fluorophores.  
In the design of the probe there are few criteria to be fulfilled: 
• Delivery. The way fluorescent probe is introduced and distributed in the living 
system cannot affect the physiology and structure of the cell. The chemical 
character play here crucial role. If the probe has a lipophilic character it can enter 
the cell only by the addition of small-volume water-miscible stock solution. Cell 
population analysis with flow cytometry or spectrofluorometry requires bulk loading 
procedures, such as membrane-permeant acetate, acetoxymethyl ester 
derivatives (Tsien, 1981), acid loading (Bush and Jones, 1990), hypo-osmotic 
shock (Nolan et al., 1988) or electroporation (Bright et al.,1996). One interesting 
development in the field is the application of cationic liposomes to load the F-actin 
probe BODIPY FL phallacidin into live neuronal cells (Barber et al., 1996). 
• Targeting. The probe should come into interaction with a biological sample in a 
selective manner. Common visualization of this aspect is to think about the probe 
as a molecule involving two functional compartments – a fluorophore and a 
targeting group. Both are equally important, nevertheless quality of the fluorophore 
will determine image resolution – this is why ease of functionalization is of high 
importance. 
• Detectability. Photophysical properties of the probe must be consistent with the 
instrumentation that is applied for the detection. The signal must be sufficient at 
concentration levels that correspond to the natural abundance in the cell. 
Detectability is closely related to a few spectroscopic characteristics of the probe 
being: extinction coefficient and fluorescence quantum yield, photobleaching, 
excitation wavelength and, Stokes shift. 
• Fluorescence response. This describes how the interacting probe is going to be 
detected (e.g. imaging spatial distribution of fluorescence or spectroscopic 
response such as spectral shift). Intracellular environment usually affects 
fluorescence sensitivity (even though there cases where its lack is advantageous). 
Globally this can be used to generate a change of fluorescence intensity in 
response to the interaction of the probe with its target. [36] 
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Small molecules as fluorescent probes 
possess few assets over fluorescent 
proteins (FPs) - most importantly their size, 
ease of functionalization and Near Infra-Red 
(NIR) fluorescence. [37] Widely used 
fluorophores include coumarin, fluorescein, 
BODIPY, rhodamine and cyanine dyes 
(Figure 27) and cover a wide range of 
fluorescence depending on π-conjugation 
and effect of a moiety attached.  
 
 5.1.2 Structure and physicochemical properties of BODIPY dyes 
4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene abbreviated as BODIPY is a 
compound with interesting electronic properties and a large variety of derivatives. The 
chromophore structure and structure investigated in this work are presented in Figure 28. 
The advantages are quite numerous and application range includes biomolecular labels, 
drug delivery agents, fluorescent switches, electroluminescent films, dye lasers, light-
harvesters, and sensitizers for solar cells. [38]  
Significant in biochemical/biological research property is a 
strong UV absorption and a relatively sharp emission 
spectrum with a quantum yield close to 1. One of the first 
BODIPY structures was reported in 1968 by Treibs et al. 
[39] but the first non-functionalized core was synthesized in 
2009 and published independently by three groups. 
[40][41][42] These dyes are insensitive to the polarity and 
pH of the environment (as a general trend, with certain 
exceptions reserved for some derivatives). The BODIPY 
chromophore is relatively non-polar and electrically neutral 
molecule with planar geometry. The emission profile is tuned easily upon binding to 
proteins or DNA. Another important advantage is a small Stokes shift, making them, as 
mentioned before, a good match for imaging. Focusing specifically on cellular biology 
Figure 27. Examples of small molecules widely 
applied in cellular imaging as a fluorescent probes. 
Figure 28. Top: chemical structure 
of the chromophore of BODIPY. 
Bottom: BODIPY utilized in this 
work (also referred as 
pyrromethene597). 
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there are drawbacks of those. Most of the BODIPY’s emit at wavelengths lower than 600 
nm and only handful of water-soluble dyes are commercially available. The potential of 
those is yet unrealized in living cell imaging and further developments are required. Their 
chemistry was extensively explored and synthetic routes are described in a review by 
Loudet et al. (2007) [47] explicitly for molecular biology applications. Many states that high 
photostability of pyrromethenes makes them superior to rhodamine dyes, texas red or 
fluorescein. [43][44]   
Some BODIPY derivatives exhibit specific affinity toward some amino acids. [51]  The 
selectivity of the probe towards certain amino acids was assessed by using  optical 
spectroscopies (here absorption and fluorescence). Spectral changes upon titration (from 
fluorescence emission intensity evolution) revealed that BODIPY derivatives  have a  
strong affinity  for cysteine and homocysteine.  
 
 5.2 Synthesis and functionalization of BODIPY dyes 
 5.2.1 From pyrroles and acid chlorides or anhydrides 
A common approach to get functionalized core of BODIPY is to hit meso position 
first via a condensation reaction of acyl chlorides with pyrroles. Such reaction involves 
unstable intermediate of dipyrromethene hydrochloride salt formation which makes a little 
easier to handle and purify due to increased C-substitution. Reaction scheme is presented 
in Figure 29A. Acid chlorides are not unique here and can be substituted with other 
carboxylic acids derivatives. Another approach includes glutaric anhydride as a starting 
reagent and has an interesting feature of free carboxylic acid at meso position, which can 
be further used to attach the dye to a target molecule. The scheme presented in Figure 
29B. 
 
 5.2.2 From pyrroles and aldehydes 
The similar synthetic approach combines oxidation steps and aromatic aldehydes 
as reagents. Oxidation reactions can possess some experimental inconveniences, such 
as byproduct removal. Figure 29C shows such reaction with use of p-chloranil as an 
oxidant.  
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If one aims at obtaining α,β-unsubstituted BODIPY, it can be done starting from aldehydes 
and is believed to be an elegant approach requiring mild conditions. It is enough to 
dissolve aldehyde in excess of pyrrole at 25 °C and dipyrromethene intermediate is 
obtained (and furtherly isolated). The final product is formed during oxidation with 2,3-
Dichloro-5,6-Dicyanobenzoquinone (DDQ) and complexation with boron. The scheme is 
shown in Figure 29D. 
The broad scale of possibilities would offer use of halogenated benzaldehydes as for 
compound in reaction 3. This contributed to the development of a long chain acid 
substituents and in fact were successfully applied to study dynamic effects in membranes 
(structures on Figure 29E). Moreover, ortho-substitution on the meso-aromatic groups 
restrict moiety rotation and contribute to higher quantum yields.[45] For this approach 
number of possibilities are reported in the literature and their choice depends purely on 
purpose. Shortly, condensation reactions of pyrroles with either acid chloride or 
benzaldehyde derivatives are considered convenient and direct methods for symmetrical 
BODIPY preparation. 
 
 5.2.3 From ketopyrroles 
Last synthetic route outlined here is devoted for unsymmetrically substituted 
BODIPY. This includes (generally) preparation of ketopyrrole intermediate followed by a 
Lewis acid mediated condensation with another pyrrole fragment. Magnesium anions of 
pyrroles upon reaction with an activated carboxylic acid derivative give 2-ketopyrroles.[46] 
Then it is followed by condensation of ketopyrroles with another pyrrole to result in 
BODIPY structure. Even though it gives mainly symmetrical product this method is also 
applied for unsymmetrically substituted ones (Figure 29F). 
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Figure 29. Synthetic routes for BODIPY functionalized chromophore. Description of reactions in the text in 
chapter 5.2. Reaction schemes taken from [47]. 
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 5.3 Bovine Serum Albumin as a model protein 
One of the issues when dealing with BODIPY dyes is the solubility. Hydrophobic 
variants of BODIPY are easily available and relatively low-priced compared to 
functionalized ones. Still, there is another way round to overcome this problem. 
Incorporation of the probe into a protein would own a great advantage of water solubility 
and hence delivery problems with no need for harsh chemical conditions and provide an 
instant idea about targeting since the protein would be localized in protein-specific 
organelles. In PDB there is only one structure of this kind, under accession code 2ZK6. It 
is a structure of a human peroxisome receptor with functionalized BODIPY derivative. 
Even though that study concerns a receptor with multiple affinities, it has a highly helical 
structure, thus BSA might be an interesting target too. 
Serum albumins (also known as blood albumins) are well-known proteins found in 
vertebrate blood. Mammalian serum albumins are believed to be chemically similar. They 
are synthesized in the liver and spread into blood plasma (in fact it is most abundant blood 
protein in mammals). Albumin is synthesized in the liver as preproalbumin which has an 
N-terminal peptide that is removed before the nascent protein is released from the rough 
endoplasmic reticulum. The product, proalbumin, is in turn cleaved in the Golgi vesicles 
to produce the secreted albumin. [48] There they are responsible for maintaining the 
oncotic pressure that is essential for delivery of body fluids between blood vessels and 
body tissues. It also acts as a transporter by non-specifically binding hydrophobic steroids, 
thyroid hormones, hemin and fatty acids.  
Serum albumins show several advantages such as being globular proteins, stable in terms 
of folding, water-soluble, and structurally well characterized. For all these reasons they 
are very often used as model proteins. From more practical view Bovine Serum Albumin 
(BSA) is a commercially available material. In biochemistry, immunology and 
biotechnology BSA is commonly used in Enzyme-Linked Immunosorbent Assay (ELISA), 
immunocytochemistry, immunoblots and in a stabilization of restriction enzymes. Due to 
lack of interference with many biological reactions, it is used as a universal blocking agent.  
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The molecular weight of BSA lays around 66 kDa with a α-helical structure (maintaining 
static shape for blood pressure regulation) – Figure 30. Within serum albumin structure 
there are eleven hydrophobic 
pockets for hemin and fatty 
acids. In total there are seven 
sites for long and medium 
sized fatty acids (Ashbrook et 
al., 1972, 1975), four sites for 
short fatty acids 
(Bhattacharya et al., 2000), 
two sites for drugs (Sudlow et 
al., 1975, 1976), one site for 
bilirubin (Zunszain et al., 
2008) and, five sites with affinity for thyroxine (Petitpas et al., 2003). All albumins are 
cysteine-rich proteins (thus are interesting targets for BODIPY in terms of the cysteine 
affinity) and sequence alignment for BSA, HSA, ESA, and LSA had shown that their 
similarity level is very high. First three-dimensional structure of BSA was deposited in 
2012 at resolution 2.47 Å (PDB ID: 4F5S).  
 
 
 
 
 
 
 
 
 
Figure 30. Crystal structure of BSA subunits. 
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Chapter 6 - Methods and experimental fine points 
 6.1 Chemicals and sample preparation 
Bovine serum albumin (BSA) in a form of lyophilized powder was purchased from 
Sigma-Aldrich (St. Louis, MO, USA), and pyrromethene597 was purchased from Exciton 
(Dayton, OH, USA). 
Adduct preparation of pyrromethene597 and BSA was varying a little from case to case, 
but as a general trend ratio of protein:probe was between 10 and 20 fold dye excess with 
different stirring methods (magnetic stirrer, rocking platform, bath and microtip sonication): 
Method 1: For an absorption experiments the protocol incorporate protein:dye at ratio 
~1:20 (0.25 mM for BSA and 5.5 mM for pyrromethene597 in water) and left under 
magnetic stirring for 48 hours. Then sample was centrifuged (10.000 rpm, 4 °C for 10 
minutes) and taken for DLS. Protein reference solution had concentration of 0.25 mM 
(in water). 
Method 2: In the second protocol applied in both absorption and fluorescence 
experiments protein:dye ratio was kept around ~1:10 (0.5mM for BSA, 5mM for 
pyrromethene597 in water). One fraction of the sample was taken for sequential 
sonication (5x10 minutes cycles of microtip sonication - in total 50 minutes) and 
remaining fraction for magnetic stirring (24 hours). Then samples were centrifuged 
(10.000 rpm, 4 °C for 10 minutes) and taken for DLS measurement. 
 
 6.2 Absorption and fluorescence spectroscopies 
Absorption and fluorescence spectroscopies belong to the family of optical 
techniques aiming at the determination of various sample properties, such as 
concentration and photo-physical properties. Both are based on photon interaction with a 
dye/protein molecule, being here absorption and subsequent emission.  
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Overview of the 
processes in a simplified 
way is presented in Figure 
31. The fluorophore (dye 
molecule or aromatic 
residues of the protein) 
can be in two different 
states with specific 
energy gap ∆E. Absorption occurs when an incident photon of matching wavelength (or 
energy) hits the molecule in the ground state and brings it to the excited state so that the 
photon is absorbed in the process. The condition of the photon to be absorbed must fulfill 
the following energy relation: 
Ephoton = ∆E 
Fluoresce is a process altering absorption. If the excited molecule returns to its ground 
state, the energy ∆E′ has to be deposited in some way. One of the possibilities is a 
radiative relaxation, or simply emission of a fluorescence photon carrying the energy of 
the gap ∆E′. The way the energy is dissipated from the excited state depend on the dye 
character, and in the case of the fluorescent probe, it is a dominant path.  
 
 6.2.1 Absorption theory and experimental conditions 
Most elementary law describing the effect of an absorption is Beer-Lambert law in 
the case where light passes through the material (sample). The decrease in transmitted 
light (absorbance) is 
connected with the 
material properties. The 
scheme of an 
absorption 
measurement is 
depicted in Figure 32. This law may be rewritten in terms of an absorption A that express 
relative decrease of intensity in a logarithmic scale:  
Figure 31. Absorption of an incident photon and emission of a 
fluorescence photon in a simplified fluorophore electronic state system. 
Figure 32. Set up of an absorption experiment. 
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A = log10
I0
I
 
Where I0 and I are the intensities before after passing through the sample. In protein 
science, a very often used term for absorption is Optical Density (OD), for instance, if the 
OD=1 this means that only 10% of light passes through the cuvette (hence 90% is 
absorbed). The Beer-Lambert law is generally written as: 
A = ε(λ) ∙ L ∙ [C] 
Where [C] is the sample concentration, L is the optical path length. ε(λ) is a molar 
absorptivity and is a wavelength dependent coefficient expressed in M−1cm−1. For 
example, the molar absorptivity of the probe utilized in this study is: 
Pyrromethene597 (ethanol): ε(525) = 68000 M−1cm−1 
Using Beer-Lambert law concentration can be easily assessed by the measurement of I0 
and I, given the path length and absorptivity of the molecule. Other way is plot absorption 
against a series of concentration and reading out the slope that gives ε(λ) ∙ L. 
Absorption experiment 
also gives the possibility 
of identifying various 
components of the 
sample with absorptivity, 
for example DNA, 
proteins or fluorescent 
dyes. The measurement with absorption spectrometer (Figure 33) is absolute, meaning 
independent of the spectrometer and standing for a comparison between two measured 
intensities (thus reference sample is taken first to get rid of an influence of the solvent). 
[49]  
In this thesis, all absorption experiments were performed with Cary 300 Bio UV-Visible 
Spectrophotometer in quartz cuvettes (with cell path length 10 mm) in the wavelength 
range 200 – 800 nm (scan rate 600 nm/minute). 
Calibration curve for pyrromethene597 was prepared in a concentration range 0.136 mM 
and 0.0136 mM  (for the peak at 523 nm) and 0.1 mM – 0.005 mM for BSA (for the peak 
at 278 nm). 
Figure 33. Scheme of an absorption experiment. 
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 6.2.2 Fluorescence theory and experimental conditions 
Fluorophores or 
fluorescent dyes (usually 
polyaromatic 
hydrocarbons or 
heterocycles) are 
exhibiting fluorescence 
as a result of a three-
stage process in their 
electrons shell. This can 
be visualized with a 
simplified Jablonski 
diagram as in Figure 34.  
The first process is an excitation of the sample. The external light source (such as a laser) 
supplies a photon of an energy hVex and gets absorbed by a fluorophore. This energy 
pushes an electron from its ground state (S0) to the excited state  (S1). Absorption takes 
place in around 1 fs (10-15 s). The 
second process is a non-radiating 
transition. On average the electron 
spends 1 – 10 ns in the excited state.  
In this time domain, the fluorophore 
can undergo conformational changes 
and can interact with its molecular 
environment. Non-radiative transition 
entails two major consequences. First, the energy of S1 sub-states is dissipated to some 
extent giving rise to singlet excited state from which fluorescence comes. Second, not all 
molecules excited by a photon will reach back the ground state by fluorescence. This 
means there may be other processes involved such as collisional quenching, fluorescence 
energy transfer, and intersystem crossing and hence depopulate S1 without a photon 
emitted. The last process is a fluorescence emission. The fluorophore can return to its 
ground state by emitting a photon of an energy hVfl and reaching S0 state. The energy of 
Figure 34. Simplified Jablonski diagram for the fluorescence emission with 
an exemplary spectra generated by combining absorption and emission 
spectra. 
Figure 35. Excitation and emission spectra of a fluorophore. 
Spectra plotted at three wavelengths  (EX1, EX2 and EX3). 
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such photon is lower due to energy dissipation during the excited state lifetime and thus 
has a longer wavelength than the excitation photon hVex. This energy difference is directly 
related to so-called Stokes shift which can be expressed as a difference between 
absorption and emission maxima: 
∆λStokes = λmax.emission − λmax.absorption 
The fluorescence process is cyclic (unless the fluorophore is irreversibly damaged - 
photobleaching) meaning the fluorophore can be continually excited and detected. For the 
case of polyaromatic molecules in a solution, the distinct electronic transitions represented 
by hVex and hVfl are swapped by broad energy spectra named fluorescence excitation 
spectrum and fluorescence emission spectrum (schematically represented in Figure 35).  
The width of each spectrum is of importance in applications that concern two or more 
fluorophores detected simultaneously.   
With some uncertainty, the fluorescence spectrum of a single dye species in a solution is 
identical to its absorption spectrum (mirror-like). If applied conditions are the same the 
shape of fluorescence emission is independent of the excitation wavelength. The emission 
intensity is proportional to the amplitude of a fluorescence excitation spectrum at the 
excitation wavelength. 
Fluorescence spectrometer consists of a monochromatized excitation light source and a 
detection channel (also with monochromator). The detection channel is placed at the 
angle of 90° to avoid the detection of transmitted light. Fluorescence spectrometer can be 
used in two modes: 
• Detect emission spectra – where the excitation wavelength is fixed and detection 
takes place over a range of energies, resulting in the emission spectrum of the 
sample. 
• Detect excitation spectra – where detection wavelength is fixed and the excitation 
energies are scanned – resulting in the excitation spectrum of the sample.[49] 
The samples for the fluorescence measurement were performed on a Edinburgh F900 
fluorometer. Samples prepared according to method 2 (protocol described in 6.1 
Chemicals and sample preparation). 
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 6.2.3 Dynamic Light Scattering measurement 
The experimental conditions of DLS measurement for BSA:BODYPY complex are the 
same than those used for GR and they are described  in PROJECT1 methods. 
 
 6.2.4 Crystallization and Single Crystal X-ray Diffraction 
Method description for crystallization and XRD analysis is reported in PROJECT1 
methods. For crystallization of the protein:dye complex the conditions  described in Sekula 
et al., [50] for pure BSA, were applied. There are two reservoir solutions are: 
A: 0.2M calcium acetate, 0.1M MES (pH 6.5), 24% w/v PEG 5K; 
B: 0.175M ammonium chloride, 0.1M MES (pH 6.5), 17% w/v MES 5K; 
In addition 3 replicates were set  with pure protein  for eventual soaking experiments. The 
plate scheme is shown in Figure 36. Data were collected at ESRF Grenoble at ID23.1. 
The protein solution was maintained at a concentration of 66 mg/mL (according to the 
protocol). 2 μL of protein was placed on a siliconized coverslip and mixed with another 2 
μL of mother solution from the reservoir (700 μL). Each well was vaseline-sealed and left 
in the incubator at 20 ± 1 °C. Control check was done every week under an optical 
microscope (Leitz Wetzlab SM-LUX) equipped with a digital camera Motic 5.0 MP. 
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Figure 36. Plate for hanging drop vapor diffusion crystallization of BSA and pyrromethene 
complex. A and B indicates two different crystallization conditions taken from literature [50]. 
P597 indicates pyrromethene597 as a supposed adduct with the protein. Composition of 
reservoir solutions: A – 0.2M calcium acetate, 0.1M MES (pH 6.5), 24% w/v PEG 5K Da, B 
– 0.175M ammonium chloride, 0.1M MES (pH 6.5), 17% PEG 5K Da. 
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Chapter 7 - Results and discussion 
Fluorescent probes have always been direct ‘tools’ in achieving visual results in 
live cell imaging. The physicochemical characteristics of the probe determine the quality 
of the image and very often it is a matter with certain difficulties. This work is based on 
pyrromethene family of fluorescent dyes (BODIPY) as a robust probe in molecular biology, 
due to its excellent properties (see introduction). A cell as a fragile target needs a lot of 
care while handling, thus any additional procedure (such as staining) has to be reasonably 
designed. From BODIPY dyes group only a handful of water soluble molecules are 
available as reported by Loudet et al. (2007). 
One of the possible solutions is an incorporation of the hydrophobic probe into an easily 
available protein, such as lysozyme or BSA. The advantage of developing steady 
protocols is that the model proteins are water soluble, thermally stable and relatively 
resistant to the harsh chemical environment. This project is an attempt in achieving the 
stable protein-dye adduct for imaging purposes. Once the preparatory step was settled 
optical spectroscopies were employed to assess the quality and efficiency of the protocol. 
 
 7.1 Absorption experiments 
BSA is difficult to crystallize protein and number of operations done to incorporate 
the probe makes it even more complex target for crystallographic study. Thus techniques 
such as absorption and fluorescence emission can be employed to get useful conclusions 
about the system. As a first try absorption experiments were performed to get an idea how 
the protein adduct behave. The main issue to overcome is a strongly hydrophobic 
character of the probe thus excessive concentration was utilized to see whether it has a 
positive influence on the absorption profile of the protein band. Before the tryouts, 
pyrromethene597 methanol solution was taken for calibration curve preparation for further 
quantification. This dye has the highest solubility in methanol but adduct preparation is 
water-based due to the nature of the protein. Solubility limit for the dye is around 0.5 mM 
(in methanol) and the calibration curve with respective absorption spectra is shown in 
Figure 37. The calibration curve was prepared on absorption maxima of pyrromethene597 
thus 523 nm.  
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From the slope of the calibration curve molar extinction coefficient (ε) can be calculated. 
The theoretical value of ε (in ethanol) for pyrromethene597 is equal to 68000 M-1 cm-1 
nevertheless in the case of a spectrometer used in this work absorption maxima is 
observed at 523 nm and ε (in methanol) is equal to 49712 M-1 cm-1. This difference 
presumably comes from the instrument calibration, solvent type, and weight accuracy.  
Figure 37. Top: Calibration curve for pyrromethene597 absorption maxima at 523 nm. Bottom: Absorption 
profiles of pyrromethene597 at different concentrations (dye dissolved in methanol). 
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Figure 38A presents absorption profile in the range 200-800 nm for the protein reference 
and BSA:pyrromethene597. The low intensity of the absorption band of BODIPY indicates 
that magnetic stirring leads to formation of aggregates of BODIPY and the broad shape 
of the band indicates that the dye is not present in a monomeric form. In fact, 
pyrromethene597 is highly absorbing at 523 nm and the band appear very sharp. Figure 
38B presents size distribution in both samples with DLS. Size distribution of intensity is 
not very conclusive in this case, likely due to the aggregates in both cases dominating in 
the solution. 
 
 
After centrifugation, there was a significant amount of pellet (mainly of pyrromethene597) 
that was furtherly quantified by recovery with methanol. The starting amount of the dye 
was 1.5 mg and from the pellet (using calibration curve) 1.39 mg was recovered, meaning 
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Figure 38. (A) UV-Vis spectra of the protein reference and an adduct of BSA:pyrromethene597. Sample 
diluted 1:10 for the experiment (thus final concentration of the protein was 0.025mM and pyrromethene597 
was 0.55mM). (B) DLS size distribution by intensity, where red spectra is a BSA reference while green 
corresponds to BSA:pyrromethene597 adduct. 
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that very little amount was in fact in the solution. Thus, starting ratio between BSA and 
pyrromethene597 was 0.5 mM : 5.72 mM and the final ratio (thus after stirring and 
centrifugation) was 0.493 mM : 1.38 mM. 
Next concept was to investigate different dye molecule incorporation methodology. As the 
aggregation is pronounced, microtip sonication was applied to see if this could anyhow 
improve the condition. For this idea two mixing methods were utilized to check the 
effectiveness, one sample (protein:dye ratio 1:12) left under magnetic stirring and the 
second (same ratio) taken for sonication. UV-Vis spectra were taken after every 60 
minutes of magnetic stirring (MS) and every 10 minutes of microtip sonication (S) for 3 to 
5 cycles respectively. After the experiment, sonicated sample was left at 4 °C for 24 hours 
to check the stability of  the solution (Figure 39A). MS sample was left under stirring for 
24 hours to see if better results are obtained when protein:dye ratio is lowered compared 
to the previous case of 1:20 (Figure 39B). 
Indeed sonication was found to be much more efficient at dissolving pyrromethene597 to 
a visible extent. Less than an hour was enough to see the evident difference in an 
absorption profile. More importantly, a radical change in pyrromethene597 absorption 
band was recorded. The main peak was blue shifted by around 30 nm and did not maintain 
its spiky shape (as in calibration curve spectra).  
Decreasing the ratio from 1:20 to 1:12 worked better for MS too. Absorption maxima for 
pyrromethene597 increased from 0.2 up to 1.8 (just for different ratios) after 24 hours of 
MS. Still, maxima are less intense than in the sonicated sample but peak shifting and 
shape change is maintained. After centrifugation, DLS was taken again, but as in the 
previous method, only large aggregates are visible (~150 nm for sonicated sample and 
~250 nm for the sample under magnetic stirring). Similarly, pellet after centrifugation was 
quantified and from the starting amount of 1.6 mg of the dye, 1.1 mg was recovered 
meaning this incorporation method was more efficient than the first one. The starting ratio 
of BSA and pyrromethene597 was 0.25 mM : 3.11 mM, while after sonication and 
centrifugation ration decreased to 0.248 mM : 1.88 mM. 
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Figure 39. (A)UV-Vis profile of protein:dye adduct prepared with microtip sonication. Sample was sonicated 
for 50 minutes in total and spectra was acquired every 10 minutes. The green spectra stands for the sample 
analyzed after 24 hours 'rest' at 4 °C. (B) UV-Vis profile of protein:dye adduct left under magnetic stirring. 
Spectra acquired every hour and left for 24 hours at room temperature. 
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From the absorption and DLS experiments it is possible to hypothesize that BODIPY form, 
in the aqueous protein solution, aggregates with a hydrodynamic radius bigger than 50 
nm in the case of sonication and 100 nm in the case of magnetic stirring, surrounded and 
stabilized by several BSA molecules. Since BODIPY alone in water solution form bigger 
and irregularly sized aggregates (Figure 40; Hydrodynamic radius about 522 nm) it can 
be concluded that the BSA has a major role in stabilizing BODIPY particle in solution 
preventing high aggregation.   
 
 
 7.2 Fluorescence experiments 
After absorption experiments, we have performed emission spectroscopy measurements 
to gain an insight on molecular and aggregated BODIPY in the BSA solution. Emission 
spectra revealed that the emission of BODIPY does not show significant variations 
compared with BODIPY in methanol. For this fluorescence lifetime, experiments provided 
some basic information about their photophysical specificity. In addition to the previous 
protocols with magnetic stirring and sonication, a separation step was employed – viva-
spin. The sample as being at unknown state, the viva-spin separation was utilized with 
the pore size suitable for separation of proteins up to 100 kDa. This in fact eliminated the 
larger aggregates. Since sonication was found to be more efficient, MS samples were not 
taken for further consideration. Figure 41 presents fluorescence emission from two 
samples: sonicated (protein:dye at ratio ~1:10) and the same sample taken for viva-spin 
separation (10 minutes, 10000 rpm at 4 °C). Excitation spectra confirmed indeed that the 
Figure 40. DLS profile of BODIPY water solution (0.04 mM) prepared with microtip sonication 
(60 minutes). Size distribution by intensity indicates irregular aggregates in the range between 
80 - 522 nm. 
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observed emission only comes from monomeric BODIPY (thus featuring the same 
absorption spectrum as BODIPY in methanol). On the contrary the additional band 
observed in the absorption spectrum does not lead lead to emission. This allows for 
identification of those bands as the bands of not emissive aggregates dispersed in a 
solution, while the little emission might arise from monomeric BODIPY embedded inside 
BSA protein. 
 
Figure 41. Fluorescence spectra for protein:dye complex. The orange spectrum is a sample taken for 50 
minutes sonication, while the grey one was additionally taken for viva-spin separation. 
 
Separation procedure significantly reduced the number of aggregates as observed in 
fluorescence lifetime for both samples (Figure 42). From fluorescence emission, it is seen 
that concentration is drastically reduced for the sample with a separation step. 
 
 
Figure 42. Fluorescence lifetime for sonicated adduct (blue) and sonicated/separated sample (orange). 
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Just from the fluorescence lifetime profile, it is seen that sonicated/separated sample has 
a lower contribution of one exponential component. For both spectra the fit has two 
exponential components,  indicating two different emissions ‘characters’. The fitting was 
done in software FAST for fluorescence emission data processing, according to the 
formula for the double-exponential decay of fluorescence intensity: 
I(t) = A1 exp (−
t
τ1
) + A2 exp (−
t
τ2
) 
Where  
I(t) – fluorescence intensity, 
A1, A2 – pre-exponential factors, 
τ1, τ2 – lifetimes, 
𝑡 – pulse time. 
Fittings with superimposed spectra for both samples is shown in Figure 43. Table 6 
presents fitting parameters calculated in the software FAST. 
 
Table 6. Fitting parameters for sonicated and sonicated/separated sample. 
Sample type A1 A2 τ1 [ns] τ2 [ns] 
Sonicated sample 1612.54 605.5 0.341 6.079 
Sonicated/separated 
sample 
949.8 947.14 0.644 6.23 
 
 
Figure 43. Fluorescence lifetime for sonicated protein:dye solution (blue) and sonicated and viva-
spin separated solution (red). 
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Last, but not least fluorescence measurement was the lifetime analysis at different 
emission wavelengths. Figure 44 presents measurements where the excitation 
wavelength was 405 nm and emission lifetime measured in the range 520 – 700 nm. This 
measurement was done for sonicated/separated sample. Even though the number of 
aggregates was supposed to be decreased, the overlapped spectra show a clear 
contribution of a differently emitting form of pyrromethene597. For the wavelengths of 520 
and 540 nm, the profile is maintained as in Figure 43 (red line) thus ‘more emitting’ 
structure. From 560 nm and on, the emission undoubtedly changes its behavior, thus 
probably it is the energy range where the separate form of pyrromethene597 is emitting 
(supposed aggregates and/or nanoparticles). 
 
Figure 44. Emission profiles of sonicated/separated protein:dye sample. Excitation wavelength was equal 
to 405 nm and emission lifetime measured in the range from 520 nm up to 700 nm. 
 
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
0 10 20 30 40 50 60
C
o
u
n
ts
Time [ns]
Emission520
Emission540
Emission560
Emission580
Emission600
Emission620
Emission640
Emission660
Emission680
Emission700
82 
 7.3 Crystallographic study 
BSA crystal structure was resolved quite recently (2012) and the best resolution 
found on PDB is 2.47 Å. Thus without trials, the methodology was reproduced for this 
study. Bujacz et al.(2012) reported two reservoir solutions suitable for BSA crystallization 
(composition in 6.2.4 Crystallization and Single Crystal X-ray Diffraction). According to 
this protocol crystals should be formed after seven days. In this case, it was a condition 
difficult to reproduce and after one week, crystals were observed only for 
BSA:pyrromethene597 adduct (luckily). In addition (as shown in methodology chapter) 
BSA was crystallized in a pure form (in water or buffer) for eventual soaking trials. After 3 
months few crystals of pure BSA were observed, meaning the conditions are right but the 
time of crystal growth is not reproducible. Figure 45 shows results of the BSA and 
BSA:pyrromethene597 crystallization. After one week crystals for BSA:pyrromethene597 
were observed (thus conditions C3/A/BP, C4/B/BP, and D1/A/BP). Those were taken for 
XRD analysis at ESRF Grenoble (ID 23.1 beamline). One peculiarity spotted was no 
influence of buffer in the protein sample, at least no visible trend. On Figure 45 condition 
A3 and B1 show BSA in water while A4 and B4 is a BSA sample in the buffer. Thus 
morphology is affected by the reservoir solution and not buffer addition in the protein 
preparation step. 
Figure 45. Images of crystallization positive hints. Naming scheme: well#/crystallization condition/sample 
(where B stands for BSA and BP for BSA:pyrromethene597). Scale bar in the top left corner indicates 70 
µm. 
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Data collection, phase problem solution, and model building procedure were just like in 
PROJECT1. The structure solution  was definitely less time-consuming due to BSA model 
availability and sequence identity of 100%. Data collection details are presented in Table 
7. During model building, certain densities were identified that could be assigned as a 
pyrromethene597 molecule (Figure 46 top). Then a BODIPY molecule was built inside, 
but unfortunately in the subsequent  refinement cycle, the density disappeared. This 
phenomenon can be due to a low occupancy of the dye in the protein binding sites or to 
a local disorder of the dye, both cases producing a weak electron density map preventing 
correct model building and structure refinement.  
 
 
 
 
 
Figure 46. Example of pyrromethene597 fitting and subsequent refinement 
cycle. Only experimental density is shown (F0). 
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Table 7. Data collection parameters for BSA:pyrromethene597 crystals. 
Parameter BSA:pyrromethene597 
Data collection 
Unit cell 
a=216.8 Å, b=44.4 Å, c=140.3 Å, α= 90°, 
β=114.1°, γ=90° 
Space group C 1 2 1 
Resolution range* (Å) 98.942 – 3.039 Å (3.091 – 3.039 Å) 
Unique reflections 1691 
Completeness* (%) 99.8 (99.5) 
Rmerge* 5.2 (78.0) 
I/σ 8.9 (2.1) 
Multiplicity 6.6 (6.8) 
 
 7.4 Conclusions 
Optical spectroscopies were found to be useful tools in understanding behavior of 
the protein:dye system. Hydrophobic nature of the fluorescent probe turned out to be more 
complex in a protein solution than expected. Absorption and fluorescence experiments 
were successfully employed in the primary assessment of what might be happening during 
sample preparation. Formation of aggregates with irregular dynamic performance is 
somewhat unavoidable. Stability of the system can be progressed by applying sonication 
step in the adduct preparation protocol. 
One powerful method to investigate whether pyrromethene597 is incorporated into BSA 
structure would be mass spectrometry analysis. This could possibly give a rapid idea if in 
the solution protein adduct is present, thus protein molecular weight increased by the 
mass of pyrromethene597 as a molecular ion peak. This approach was taken into 
consideration from the early stages of the project, however, due to instrument availability 
limitation, it was not possible until the thesis submission deadline.  
Having grown crystals of BSA also trials with soaking in pyrromethene597 solution will be 
considered in nearby future. Another approach will include the application of various (and 
commercially available) pyrromethene probes and eventually utilization of other model 
proteins (such as lysozyme). 
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Additional information 
1. Reagent solution lists for crystallization trials optimization: 
• Manually prepared reagent solutions (based on trials from MD1-01-CF) 
• Crystal Extension kit (Crystal Screen 2) – Hampton Research 
• JCSG-plus MD1-37 for soluble proteins  - Molecular Dimensions 
 
 
Manual reagent solutions 
Tube# Salt Buffer pH Precipitant 
18A 0.2M sodium acetate 0.1M MES 6.5 18% PEG 8K 
18B 0.2M sodium acetate 0.1M MES 6.5 18% PEG 4K 
18C 0.2M magnesium chloride 0.1M MES 6.5 18% PEG 8K 
18D 0.2M magnesium chloride 0.1M MES 6.5 18% PEG 4K 
18E 0.2M sodium acetate 0.1M HEPES 7.5 18% PEG 8K 
20A none 0.1M MES 6.5 18% PEG 8K 
20B 0.2M calcium acetate 0.1M HEPES 7.5 18% PEG 8K 
31A none 0.1M HEPES 7.5 20% PEG 4K 
33A 0.2M magnesium chloride 0.1M Tris 8.5 25% PEG 4K 
33B 0.2M magnesium chloride 0.1M Tris 8.5 20% PEG 4K 
33C none 0.1M Tris 8.5 30% PEG 4K 
33D 0.2M calcium acetate 0.1M Tris 8.5 30% PEG 4K 
33E 0.2M ammonium acetate 0.1M Tris 8.5 30% PEG 4K 
33F none 0.1M Tris 8.5 18% PEG 8K 
33G 0.2M calcium acetate 0.1M Tris 8.5 18% PEG 8K 
33H 0.2M ammonium acetate 0.1M Tris 8.5 18% PEG 8K 
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